WO2019189398A1 - Luminal organ bypass stent and stent delivery system including luminal organ bypass stent - Google Patents

Luminal organ bypass stent and stent delivery system including luminal organ bypass stent Download PDF

Info

Publication number
WO2019189398A1
WO2019189398A1 PCT/JP2019/013257 JP2019013257W WO2019189398A1 WO 2019189398 A1 WO2019189398 A1 WO 2019189398A1 JP 2019013257 W JP2019013257 W JP 2019013257W WO 2019189398 A1 WO2019189398 A1 WO 2019189398A1
Authority
WO
WIPO (PCT)
Prior art keywords
stent
hooking
portions
length
end portion
Prior art date
Application number
PCT/JP2019/013257
Other languages
French (fr)
Japanese (ja)
Inventor
志明 権
Original Assignee
日本ゼオン株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日本ゼオン株式会社 filed Critical 日本ゼオン株式会社
Priority to JP2020509211A priority Critical patent/JP7351292B2/en
Publication of WO2019189398A1 publication Critical patent/WO2019189398A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents

Definitions

  • the present invention relates to a luminal organ bypass stent and a stent delivery system for delivering the stent to a predetermined position in the body.
  • EUS-BD ultrasound endoscopic guided biliary drainage
  • Examples of the stent used in EUS-BD include a covered stent obtained by coating the surface of a metal stent substrate with a cover material made of a polymer film.
  • a covered stent that is suitably used for EUS-BD has been proposed that has a hooking portion for preventing migration and preventing damage to a visceral wall (see Patent Document 1).
  • the digestive tract such as the stomach can be greatly deformed, it is resistant to the deformation of the luminal organ with respect to the stent for bypassing the luminal organ for bypass connection between the luminal organ and other luminal organs. It is required to further improve the migration prevention function so that the bypass is maintained.
  • the present invention has been made in view of such a situation, and an object of the present invention is to provide a lumen-organ bypass stent having a migration preventing function and a stent delivery system including the same.
  • a stent for bypass between luminal organs A stent for bypassing a luminal organ for bypassing a luminal organ and another luminal organ, An elongated cylindrical body connected in the circumferential direction; A curve that curves to the outside of the main body portion along a longitudinal direction from a proximal end portion connected to a first end portion that is one of both axial end portions of the main body portion toward a distal end portion that is a free end.
  • a plurality of first hooking portions that have a shape and are not connected to each other in the circumferential direction;
  • an intermediate portion between the distal end portion and the proximal end portion includes a plurality of first portions having a first length in the width direction orthogonal to the longitudinal direction, and the first portion And at least one second portion having a second length that is longer than the first length and sandwiched on both sides in the longitudinal direction by one portion.
  • the interluminal organ bypass stent according to the present invention has a first portion and a second portion having different lengths in the width direction at the intermediate portion of the first hooking portion.
  • the two portions or the boundary between the first portion and the second portion functions as an anchor that prevents the stent from moving from the indwelling position. Therefore, such a lumen-organ bypass stent can effectively prevent migration.
  • the plurality of first hooking portions are arranged adjacent to each other in the circumferential direction, and the first type of the first hooking portion and the second type of the first hooking are different in shape from each other.
  • Part may be included, Regarding the position in the longitudinal direction, the second part is disposed in the first hooking part of the second type at the position where the first part is disposed in the first hooking part of the first type. Also good.
  • Stent for bypassing a luminal organ in which the first type and the second type in which the positions in the longitudinal direction of the first part and the second part in the first hooking part are interchanged are arranged adjacent to each other in the circumferential direction Since the second portions are densely formed without overlapping each other in the width direction, even when the second length of the second portion is increased, each of the second portions is accommodated in the stent delivery system. The two portions are less likely to interfere with each other, and by making the second length longer, it is possible to have a better migration prevention function. In addition, the ease of extrusion when releasing from the stent delivery system is also good.
  • the base end portion may be curved toward the tip end portion so that an angle with respect to the axial direction changes over 90 °.
  • the curved shape of the first hooking portion is not particularly limited, but the first hooking portion is curved so that the angle with respect to the axial direction changes beyond 90 ° from the proximal end portion toward the distal end portion.
  • the resistance force that occurs when the curved shape is stretched is increased. Therefore, the luminal-organ bypass stent having such a first hooking portion has an even better migration preventing effect.
  • a part of the intermediate portion on the base end portion side may be located outside the first end portion with respect to the axial direction.
  • the other part of the intermediate portion on the tip portion side or the tip portion may be located inside the first end portion with respect to the axial direction.
  • the first hooking portion touches the inner wall of the hollow organ, and thus the force that pushes the end of the main body into the inner side of the hollow organ. Therefore, the effect of preventing further migration can be achieved.
  • the interluminal organ bypass stent according to the present invention is directed from the proximal end portion connected to the second end portion which is the other of the both end portions of the main body portion to the distal end portion which is a free end. It has a curved shape that curves to the outside of the main body portion along the longitudinal direction, and may further include a plurality of second hooking portions that are independent from each other in the circumferential direction, In the second hooking portion, an intermediate portion between the distal end portion and the proximal end portion includes a plurality of first portions whose length in the width direction orthogonal to the longitudinal direction is a first length, and the first portion One part may include at least one second part sandwiched on both sides in the longitudinal direction and having a second length that is longer than the first length in the width direction.
  • the first hooking portion and the second hooking portion connected to both ends of the main body portion both act as anchors that prevent deviation from the indwelling position, Migration can be prevented more effectively.
  • the second hooking portion may have an angle with respect to the axial direction exceeding 90 ° from the base end portion toward the tip end portion.
  • the second hooking portion Since the second hooking portion is curved to exceed 90 ° with respect to the axial direction, a resistance force generated when the curved shape of the second hooking portion is extended becomes larger.
  • the stent for bypassing a luminal organ having a portion has a better migration preventing effect.
  • a part of the base end portion side in the intermediate portion may be located outside the first end portion with respect to the axial direction.
  • the other part of the intermediate portion on the tip portion side or the tip portion may be located inside the first end portion with respect to the axial direction.
  • the second hooking portion touches the inner wall of the hollow organ, and thereby the force that pushes the end of the main body into the inner side of the hollow organ. Therefore, the effect of preventing further migration can be achieved.
  • a stent delivery system includes any one of the above-described stents for bypassing a luminal organ, A delivery mechanism for delivering the lumen-organ bypass stent to a predetermined position in the body.
  • FIG. 1 is a conceptual diagram showing an example of a stent delivery system according to the present invention.
  • FIG. 2 is an external view showing an example of a luminal organ bypass stent according to the present invention.
  • FIG. 3 is a cross-sectional view of the main body portion of the luminal organ bypass stent shown in FIG.
  • FIG. 4 is a partial development view showing the frame portion and the first and second hooking portions formed integrally with the frame portion in the lumen-organ bypass stent shown in FIG.
  • FIG. 5 is a partially enlarged view of the lumen-organ bypass stent shown in FIG.
  • FIG. 6 is a partially enlarged view of a luminal organ bypass stent according to a first modification.
  • FIG. 7 is a partially enlarged view of a lumen-organ bypass stent according to a second modification.
  • FIG. 1 is an external view of a stent delivery system 50 according to an embodiment of the present invention, and FIG. 1A may be abbreviated as “stent 11” (hereinafter simply referred to as “stent 11”). ) Is shown, and FIG. 1 (b) shows the distal end portion of the second state stent delivery system 50 that releases the stent 11.
  • the direction in which the stent delivery system 50 extends from the proximal end where the operation unit 60 is disposed to the distal end where the tip tip 62 is disposed is defined as the axial direction D1. I do.
  • the stent delivery system 50 includes a stent 11 and a transport mechanism 52 that transports the stent 11 to a predetermined position in the body.
  • the transport mechanism 52 includes an operation unit 60, an outermost pipe 64, an outer sheath 66, an inner shaft 68, a tip end 62, and the like.
  • the total length of the stent delivery system 50 is, for example, about 300 to 2500 mm, although it varies depending on the placement position of the stent 11, the transport route, and the like.
  • the stent 11 is accommodated in the vicinity of the distal end of the stent delivery system 50.
  • the operator of the stent delivery system 50 transfers the stent 11 to the indwelling position in the body in the first state shown in FIG. 1 (a), and then sets the stent delivery system 50 in the second state shown in FIG. 1 (b).
  • the stent 11 is released and placed at a predetermined position in the body.
  • the inner shaft 68 is provided with a tip tip provided at the distal end of the stent delivery system 50 from the operation unit 60 provided at the proximal end of the stent delivery system 50. Up to 62, it extends in the axial direction D1. In the first state shown in FIG. 1A, the inner shaft 68 is accommodated inside the outer sheath 66 and the housing 61 of the operation unit 60.
  • the inner shaft 68 has a small-diameter portion having a smaller outer diameter than other portions in the vicinity of the distal end.
  • the small diameter portion at the distal end is exposed.
  • a guide wire lumen for passing the guide wire is formed inside the inner shaft 68.
  • a distal tip 62 is provided at the distal end of the inner shaft 68, and a through hole communicating with the guide wire lumen of the inner shaft 68 is formed in the distal tip 62.
  • the tip 62 is made of resin or the like, and has a rounded outer shape so that it can be prevented from being damaged when it comes into contact with the inner wall of the luminal organ.
  • the outer sheath 66 is movable relative to the inner shaft 68 in the axial direction D1 from the first state shown in FIG. 1A to the second state shown in FIG.
  • a proximal end of the outer sheath 66 is accommodated in the housing 61 of the operation unit 60.
  • the operation unit 60 moves the outer sheath 66 relative to the inner shaft 68 toward the proximal end side in the axial direction D1 in conjunction with the operation of the operation lever 63 attached to the housing 61.
  • the stent delivery system 50 is in the second state in which the outer sheath 66 exposes the small diameter portion of the inner shaft 68 and the stent 11 from the first state in which the outer sheath 66 covers the small diameter portion of the inner shaft 68 (FIG. 1A). (FIG. 1 (b)).
  • An outermost pipe 64 that further covers the outer periphery of the outer sheath 66 is provided in the vicinity of the operation unit 60. If the operator directly grips the outer sheath 66, the movement of the outer sheath 66 by the operation unit 60 may be hindered. However, the outermost tube 64 covers the outer sheath 66, so that such a problem can be prevented.
  • the outermost pipe 64, the outer sheath 66, and the inner shaft 68 of the transport mechanism 52 are made of, for example, a flexible resin tube.
  • a metal wire may be embedded in the resin tube used for the outer sheath 66.
  • a push ring 69 (see FIG. 1B) that pushes the stent 11 in the axial direction D1 when the stent 11 is released may be provided on the proximal end side of the small diameter portion of the inner shaft 68.
  • the ring 69 may be made of a radiopaque material.
  • tip 62 and the operation part 60 in the conveyance mechanism 52 is not specifically limited, For example, what shape
  • FIG. 2 is an external view of the stent 11 accommodated in the stent delivery system 50, and shows a state in which the stent 11 is expanded in the radial direction.
  • the stent 11 is used as an inter-luminal organ bypass stent for bypass-connecting a luminal organ to another luminal organ, and is used for ultrasonic endoscopic-guided transbiliary drainage (EUS-BD).
  • a bypass stent that is, a bypass stent that bypasses the stomach or duodenum and the bile duct or gallbladder.
  • the stent 11 is a self-expanding covered stent that contracts in the radial direction due to elasticity when a compressive force is applied in the radial direction and expands in the radial direction when the compressive force is released.
  • the lumen-organ bypass stent of the present invention is not limited to this, and may be a balloon-expanded covered stent, or may be a stent such as a tube stent that is not radially expanded.
  • the stent 11 includes an elongated substantially cylindrical main body portion 12 and a plurality of first end portions (right end in FIG. 2) R that are one of both end portions of the main body portion 12.
  • the first hooking portion 14 and a plurality of second hooking portions 15 provided at the second end portion (left end in FIG. 2) L which is the other of the both end portions of the main body portion 12.
  • the main body portion 12 includes a cylindrical frame portion 13 and a covering film portion 12 a that covers the outer periphery of the frame portion 13.
  • FIG. 4 is a partial development view showing the first and second hooking portions 14 and 15 formed integrally with the frame portion 13 and the frame portion 13 in the stent 11 shown in FIG. 2, and the stent 11 is most contracted in the radial direction. The state at the time of letting it be shown is shown.
  • the frame portion 13 is formed by struts 13a and bridges 13b, which are metal (or resin) linear members.
  • the frame portion 13 may be formed by knitting a wire, but as shown in FIG.
  • a so-called strut 13a and a bridge 13b are formed by performing laser processing or the like on a tube-like or pipe-like base material.
  • a laser cut type is preferred. If the frame portion 13 is a laser cut type, when the frame portion 13 expands in the radial direction, contraction of the length of the frame portion 13 in the axial direction D2 is suppressed, and the stent 11 can be easily placed at the intended position.
  • the cross-sectional shapes of the struts 13a and the bridges 13b constituting the frame portion 13 can be a square shape or a circular shape.
  • the direction in which the central axis C of the cylindrical main body 12 extends is the axial direction D ⁇ b> 2 in the description of the stent 11.
  • the stent 11 is housed in the transport mechanism 52 so that the axial direction D2 of the main body 12 matches the axial direction D1 of the stent delivery system 50.
  • the frame unit 13 includes a plurality of zigzag annular struts 13 a and bridges 13 b that connect adjacent struts 13 a.
  • the struts 13a are continuous in a triangular wave shape along the circumferential direction of the frame portion 13, and are connected in an annular shape.
  • the struts 13 a are connected in the circumferential direction while meandering in an S shape.
  • the bridge 13b connects the apex of the triangular wave or a part of the meandering curve portion in the adjacent strut 13a in the axial direction D2.
  • the cylindrical frame part 13 is comprised by connecting the some strut 13a.
  • the bridges 13b connecting the two adjacent struts 13a are arranged at substantially equal intervals, but the positions of the bridges 13b connecting the two adjacent struts 13a are not formed side by side in the axial direction D2. , Shifted in the circumferential direction.
  • FIG. 3 is a cross-sectional view of the stent 11 shown in FIG.
  • the surface of the frame portion 13 is covered with a coating film 12 c, and the coating film 12 c extends so as to fill between adjacent struts 13 a, and the outer peripheral surface of the frame portion 13 is covered. It is covered.
  • the outer periphery of the frame portion 13 covered with the coating film 12c is covered with a covering film portion 12a including a first polymer film 12aa and a second polymer film 12ab.
  • the stent inner peripheral surface 12b which is the inner peripheral surface of the stent 11 (main body portion 12), can be smoothed.
  • the stent inner peripheral surface 12b of the stent By smoothing the inner peripheral surface 12b of the stent, when the stent 11 is placed in the body, it is difficult for waste to accumulate on the inner peripheral surface 12b of the stent, and infections and the like are prevented.
  • the material of the coating film 12c polymers such as elastomers and resins are used, and among them, a material that dissolves in an organic solvent and has little toxicity is preferable.
  • a non-biodegradable polymer or a biodegradable polymer can be used.
  • a non-biodegradable polymer that is not easily decomposed in a living body it is particularly preferable to use polyurethane or silicone resin.
  • blend additives such as chemical
  • the method of forming the coating film 12c on the surface of the frame part 13 is not particularly limited, but a method of drying the frame part 13 after immersing the frame part 13 in a resin solution is suitable.
  • the covering film part 12a covering the outer periphery of the frame part 13 includes a first polymer film 12aa and a second polymer film 12ab.
  • the first polymer film 12aa is disposed between the frame portion 13 and the second polymer film 12ab, and covers the outer periphery of the frame portion 13.
  • the thickness of the first polymer film 12aa is preferably 4 to 20 ⁇ m as an average value of the entire first polymer film 12aa. If the first polymer film 12aa is too thick, the flexibility of the stent 11 may be insufficient. In addition, if the first polymer film 12aa is too thin, the second polymer film 12ab may not be protected from perforation by the frame portion 13 or the like.
  • the first polymer film 12aa is wound around the frame portion 13 so as to circulate the outer periphery of the frame portion 13 one or more times and less than one and a half times.
  • the second polymer film 12ab is protected from perforation by the frame part 13 and the flexibility of the main body part 12 is insufficient. Can be prevented.
  • the second polymer film 12ab is wound around the first polymer film 12aa so as to circulate the outer periphery of the first polymer film 12aa a plurality of times.
  • the material of the first polymer film 12aa and the second polymer film 12ab polymers such as elastomers and resins are used, and among them, those that dissolve in an organic solvent and have low toxicity are preferable. Also, from the viewpoint of protecting the second polymer film 12ab from perforation by the frame portion 13 while ensuring the flexibility of the main body portion 12 of the stent 11, the second polymer film is used as the material of the first polymer film 12aa. It is preferable to use a polymer having higher strength than a polymer that is a material of 12ab.
  • the total length H of the main body 12 is determined according to the distance between the luminal organs to be bypassed, but can be 10 mm to 200 mm, and preferably 40 mm to 120 mm.
  • the outer diameter D of the main body 12 when it is expanded (when no external force is applied) is determined according to the type and size of the luminal organ to be bypassed, but may be set to ⁇ 2 mm to ⁇ 20 mm. It is preferable to set it to ⁇ 4 mm to ⁇ 15 mm, and more preferably ⁇ 6 mm to ⁇ 10 mm.
  • the outer diameter of the main body 12 when contracted (when the stent delivery system is accommodated) is about a fraction of the outer diameter when expanded.
  • the wire diameter of the struts 13a constituting the frame portion 13 is preferably 0.05 to 1 mm.
  • the cross section of the strut 13a is rectangular, the length in the long side direction in the cross section of the strut 13a is 0.06 to 1 mm, and the length in the short side direction is 0.05 to 0.9 mm.
  • the outer diameter dimension of the frame part 13 is substantially the same as the dimension of the main body part 12 described above.
  • the material of the frame part 13 resin or metal is used.
  • resin used for the frame part 13 what has appropriate hardness and elasticity can be used, and it is preferable that it is biocompatible resin.
  • the resin used as the material of the frame portion 13 include polyolefin, polyester, and fluororesin.
  • the polyester include polyethylene terephthalate and polybutylene terephthalate.
  • the fluororesin include polytetrafluoroethylene (PTFE) and ethylene / tetrafluoroethylene copolymer (ETFE).
  • Examples of the metal used for the frame portion 13 include nickel titanium (Ni—Ti) alloy, stainless steel, tantalum, titanium, cobalt chromium alloy, and magnesium alloy.
  • Superelastic alloys such as Ni—Ti alloy are used. preferable.
  • a specific example of the superelastic alloy used in the frame portion 13 is a Ni—Ti alloy of 49 to 58 wt% Ni.
  • a Ni—Ti—X alloy Co, Fe, Mn, Cr, V, Al, Nb, etc.) in which 0.01 to 10.0% by weight of atoms in the Ni—Ti alloy is substituted with other atoms.
  • the mechanical properties of these superelastic alloys are adjusted by selecting the cold work rate and / or the final heat treatment conditions.
  • the frame portion 13 can be formed by processing a tube-shaped or pipe-shaped base material by, for example, laser processing using a YAG laser or the like, electric discharge processing, chemical etching, cutting processing, or the like.
  • the X-ray marker is made of, for example, an X-ray contrast material (X-ray opaque material).
  • X-ray contrast material X-ray opaque material
  • first hooking portions 14 are provided at a first end portion (right end in FIG. 2) R that is one of both end portions of the main body portion 12.
  • the first hooking portion 14 is formed of a linear, rod-like, or thin plate-like member that has elasticity and extends in the longitudinal direction D3.
  • the stent 11 includes four first hooking portions 14, but the number of the first hooking portions 14 included in the stent 11 may be two or three. It may be more than this, and is not particularly limited. Since FIG. 4 is a partial development view, only three first hooking portions 14 are shown.
  • FIG. 5 is a partially enlarged view in which the first end portion R and the first hooking portion 14 of the main body portion 12 are enlarged.
  • the main body portion 12 is connected in the circumferential direction by the struts 13a and the covering film portion 12a shown in FIG. 2, whereas the plurality of first hooking portions 14 shown in FIG. 5 are not connected to each other in the circumferential direction. being independent.
  • the first hooking portion 14 curves outward from the main body portion 12 along the longitudinal direction D ⁇ b> 3 from the proximal end portion 14 b connected to the first end portion R to the distal end portion 14 a that is a free end. Has a curved shape.
  • the first hooking portion 14 is stretched in the axial direction D2 as shown in FIG. It may be in the state. In this case, each first hooking portion 14 is attached to be bent to the outside of the main body portion 12 by its own elastic force when the stent 11 is released from the stent delivery system 50.
  • the first hooking portion 14 is formed integrally with the frame portion 13, and therefore the base end portion 14 b of the first hooking portion 14 is the frame portion 13 (frame ) Is connected to the end.
  • the cross-sectional shape of the first hooking portion 14 is not particularly limited, but may be a rectangular shape or a circular shape, and may be the same shape as the frame of the frame portion 13.
  • the first hooking portion 14 may be formed independently from the frame portion 13 and then fixed integrally by laser welding or the like, or when the frame portion 13 is formed from a base material by laser processing or the like. Alternatively, it may be cut out integrally with the frame portion 13.
  • the shape (curved shape) of the first hooking portion 14 as shown in FIG. 2 is obtained by cutting the first hooking portion 14 into the shape shown in FIGS. 4 and 5 and then cutting it out. It can shape
  • the intermediate portion 14c between the distal end portion 14a and the proximal end portion 14b has a first length L1 in the width direction D4 orthogonal to the longitudinal direction D3.
  • the first hooking portion 14 includes a plurality of first portions 14ca (four in the example shown in FIG. 5) and a plurality of second portions 14cb (three in the example shown in FIG. 5) along the longitudinal direction D3. Alternatingly arranged.
  • the length in the width direction D4 of the first portion 14ca is constant along the longitudinal direction D3 and is the first length L1.
  • the length of the second portion 14cb in the width direction D4 changes along the longitudinal direction D3, and the maximum value is the second length L2.
  • Each of the second portions 14cb has a substantially isosceles triangular plate shape having a base extending along the width direction D4 on the side close to the base end portion 14b and a vertex on the side close to the tip end portion 14a of the frame portion 13. .
  • the anchor of the second portion 14cb By making the side close to the base end portion 14b of the second portion 14c into a plate shape having a side substantially orthogonal to the longitudinal direction D3 (the direction in which the intermediate portion 14c extends), the anchor of the second portion 14cb The effect can be enhanced.
  • a slit 14d extending in the longitudinal direction D3 is formed in the first hooking portion 14, and the slit 14d passes through the center in the width direction D4 of the first portion 14ca and the second portion 14cb.
  • the base end part 14b of the first hooking part 14 is the apex part of the triangular wave in the triangular wave strut 13a constituting the frame part 13 (the state where the stent 11 is most contracted in the radial direction) at the first end R of the frame part 13. 5 are respectively connected to a meandering curve portion).
  • the distal end portion 14a of the first hooking portion 14 has a smooth outer surface as shown in FIG. 5 in order to prevent damage to the inner wall when abutting against the inner wall or the like of the luminal organ.
  • An elliptical plate-shaped tip protecting portion is integrally provided. Note that the shape of the tip protection part is not limited as long as the tip part 14a of the first hooking part 14 abuts against the inner wall or the like of the luminal organ.
  • a substantially disc shape or a substantially semi-disc shape may be used.
  • the intermediate part 14c between the base end part 14b and the front end part 14a of the first hooking part 14 is smoothly curved, and a part of the intermediate part 14c on the base end part 14b side is
  • the main body portion 12 is located outside the first end portion R with respect to the axial direction D2 (on the right (Out) side in FIG. 2).
  • the other part or the tip portion 14a on the tip portion 14a side of the intermediate portion 14c in the first hooking portion 14 is inside the first end portion R with respect to the axial direction D2 of the main body portion 12 (in FIG. 2). It is located on the left (In) side.
  • a portion of the intermediate portion 14c of the first hooking portion 14 on the proximal end portion 14b side is formed so as to be separated from the central axis C of the stent 11 toward the distal end portion 14a side. Further, in the present embodiment, a part of the intermediate portion 14c of the first hooking portion 14 on the tip portion 14a side is formed so as to approach the center axis C of the main body portion 12 as it goes to the tip portion 14a side. To the tip 14a. That is, the first hooking portion 14 is curved so that the angle ⁇ with respect to the axial direction D2 changes beyond 180 ° from the base end portion 14b toward the tip end portion 14a.
  • the shape (curved shape) of the first hooking portion 14 is not limited to such a shape, and a part of the intermediate hooking portion 14c on the distal end portion 14a side of the first hooking portion 14 is an axis line toward the distal end portion 14a side. May be formed so as to be separated from each other and reach the distal end portion 14a.
  • the first hooking portion 14 is curved so that the angle ⁇ with respect to the axial direction D2 changes beyond 90 ° from the base end portion 14b toward the tip end portion 14a, thereby enhancing the migration prevention effect. Preferred above.
  • the curved shape of the first hooking part 14 may be a uniform curvature as a whole, or the curvature may be changed continuously or stepwise as it goes to the tip part 14a.
  • the curvature of a part of the intermediate part 14c on the base end part 14b side may be larger or smaller than that of the other part of the curvature on the distal end part 14a side.
  • the curved shape of the first hooking unit 14 is not limited to a curve having one inflection point, and may be a curve having two or more inflection points.
  • the number and arrangement of the first hooking portions 14 are four, and the first hooking portions 14 are arranged substantially radially at equal angular intervals (ie, 90 °), but the number is two, three, Or five or more may be sufficient.
  • positioning of the 1st hooking part 14 may be arrange
  • the configuration (curved shape, length, etc.) of the plurality of first hooking portions 14 is the same for all (four in the present embodiment). One or more may have different configurations (curved shape, length, etc.).
  • a plurality of second hooking portions 15 are provided at a second end portion (left end in FIGS. 2 and 4) L which is the other end portion of the main body portion 12. Yes.
  • the second hooking portion 15 curves outward from the main body portion 12 along the longitudinal direction D3 from the proximal end portion 15b connected to the second end portion L to the distal end portion 15a that is a free end. Has a curved shape.
  • the second hooking portion 15 has a distal end portion 15 a, a proximal end portion 15 b, and an intermediate portion 15 c, similar to the first hooking portion 14, and the intermediate portion 15 c of the second hooking portion 15.
  • the plurality of second hooking portions 15 have the same shape and structure as the first hooking portion 14 described above except that the second hooking portions 15 are provided not at the first end portion R but at the second end portion L. Description of the detailed structure of the unit 15 is omitted.
  • the stent 11 shown in FIG. 2 and the like has the first portions 14ca, 15ca and the second portion having different lengths in the width direction D4 in the intermediate portions 14c, 15c of the first and second hooking portions 14, 15. 14cb and 15cb, the second portions 14cb and 15cb that are particularly long in the width direction D4, and the boundary portions on the base end portions 14b and 15b side between the first portions 14ca and 15ca and the second portions 14cb and 15cb.
  • it functions as an anchor that prevents the stent 11 from moving from the indwelling position in the body. Therefore, such a stent 11 can effectively prevent migration.
  • a portion of the intermediate portion 14c of the first hooking portion 14 on the base end portion 14b side is located outside the first end portion R with respect to the axial direction D2 of the main body portion 12 (on the right (Out) side in FIG. 2).
  • the distal end portion 14a (or another part on the distal end portion 14a side in the intermediate portion 14c) is located on the inner side (left (In) in FIG. 2) of the first end R with respect to the axial direction D2 of the main body portion 12.
  • the first end R of the main body portion 12 slightly protrudes from the inner wall of the luminal organ to the inside of the luminal organ and is held in the luminal organ due to the elasticity of the first hooking portion 14.
  • the first end R of the main body 12 deviates from the luminal organ, and the body cavity The event of entering the inside is prevented, and leakage of digestive fluid such as bile or digested food into the body cavity (outside the luminal organ) around the stent 11 can be effectively suppressed.
  • the 2nd hooking part 15 is provided in the 2nd end part L side of the main-body part 12, there exists an effect similar to the 1st end part R side also about the 2nd end part L side. .
  • the first hooking portion 14 or the second hooking portion 15 may be provided in only one of both end portions of the main body portion 12.
  • the present invention has been described with reference to the embodiment.
  • the present invention is not limited to the above-described embodiment, and needless to say, includes other embodiments and modifications.
  • the number and size of the second portions 14cb and 15cb included in the intermediate portions 14c and 15c of the first or second hooking portions 14 and 15 are not particularly limited, and the state of the arrangement position, the size of the stent 11, etc. It can be changed according to.
  • the shape of the second portions 14cb and 15cb is not limited to the triangular plate shape as shown in FIGS. 2 and 5, and other shapes other than the triangular plate shape such as a polygonal shape, a circular plate shape or a spherical shape are used. A shape may be adopted.
  • FIG. 6 is a partially enlarged view showing the first end portion R and the first hooking portion 114 provided at the first end portion R of the main body portion (frame portion 13) in the stent according to the first modification.
  • the first hooking portion 114 in the stent according to the second modification is different from the first hooking portion 14 (see FIG. 5) shown in the embodiment in the shape and number of the second portions 114cb in the intermediate portion 114c.
  • the intermediate portion 114c of the first hooking portion 14 includes three first portions 114ca having a first length L1 in the width direction D4 orthogonal to the longitudinal direction D3, and a first portion 114ca. And two second portions 114cb having a second length L2 in which the length in the width direction D4 is longer than the first length L1.
  • the shape of the second portion 114cb of the intermediate portion 114c is an elliptical plate shape, and the side close to the base end portion 14b and the side close to the tip end portion 14a are symmetrical.
  • Such an intermediate portion 114c also functions as an anchor that prevents the stent from moving from the indwelling position in the body, and can prevent migration of the stent.
  • the stent according to the first modification is the same as the stent according to the second embodiment except that the shape and number of the second portions 114cb in the intermediate portion 114c are different. The description is omitted.
  • the first hooking portion 114 of the stent according to the first modified example is also a distal end that is a free end from the proximal end portion 14 b connected to the first end portion R. It is the same as that of the 1st hooking part 14 about having the curved shape which curves outside the main-body part 12 along the longitudinal direction D3 which goes to the part 14a.
  • FIG. 7 is a partially enlarged view showing the first end portion R and the first hooking portion provided at the first end portion R of the main body portion (frame portion 13) in the stent according to the second modified example.
  • the stent according to the second modification includes a first type of first hooking portion 24, a second type of first hooking portion 44, and a plurality of first hooking portions provided at the first end R having different shapes. Is different from the stent 11 shown in FIG.
  • the first type first hooking portion 24 includes a base end portion 24b connected to the first end portion R, a tip end portion 24a that is a free end, a base end portion 24b, and a tip end portion 24a.
  • the intermediate portion 24c is located between the two.
  • the intermediate portion 24c is sandwiched between four first portions 24ca whose length in the width direction D4 perpendicular to the longitudinal direction D3 is the first length L1, and both sides of the longitudinal direction D3 between the first portions 24ca.
  • Three second portions 24cb having a length in the direction D4 and a second length L2 longer than the first length L1.
  • the shape of each second portion 24cb is a rectangular plate shape having two sides along the longitudinal direction D3 and two sides along the width direction D4.
  • the tip portion 24a is provided with a substantially elliptical plate-shaped tip protecting portion.
  • the second type first hooking part 44 is arranged adjacent to the first type first hooking part 24 in the circumferential direction, and is different in shape from the first type first hooking part 24. As shown in FIG. 7, the first type first hooking portion 24 and the second type first hooking portion 44 are alternately arranged in the circumferential direction at the first end R in the stent of the second modified example. Is provided.
  • the first hooking part 44 of the second type includes a base end part 44b connected to the first end part R, a free end part 44a, and an intermediate part 44c between the base end part 44b and the front end part 44a. have.
  • the intermediate portion 44c is sandwiched between two first portions 44ca having a first length L1 in the width direction D4 perpendicular to the longitudinal direction D3, and both sides of the longitudinal direction D3 between the first portions 44ca.
  • Three second portions 44cb whose length in the direction D4 is a second length L2 longer than the first length L1.
  • a through hole is formed in the base end portion 44b to form a ring shape, and the tip end portion 44a has the same length in the width direction D4 as the first portion 44ca of the intermediate portion 44c.
  • the shape of the second portion 44cb in the intermediate portion 44c is a rectangular plate shape like the second portion 24cb of the first hooking portion 24 of the first type.
  • the first portions 24ca and 44cb and the second portions 24cb and 44cb in the intermediate portions 24c and 44c The arrangement in the longitudinal direction D3 is different. That is, with respect to the position of the first hooking portions 24 and 44 in the longitudinal direction D3, the first hooking portion 44 of the second type is located at the position where the first portion 24ca is disposed in the first hooking portion 24 of the first type. Two portions 44cb are arranged. Further, in the first type first hooking part 24, the first part 44ca is arranged in the second type first hooking part 44 at the position where the second part 24cb is arranged.
  • the width between the first type first hooking portion 24 and the second type first hooking portion 44 arranged adjacent to each other in the circumferential direction is different.
  • the positions of the second portions 24cb and 44cb having a long length in the direction D4 are staggered.
  • the second length L2 of the second portions 24cb and 44cb is set as follows.
  • the second portions 24cb and 44cb are less likely to interfere with each other when housed in the stent delivery system 50, and the second length L2 is made longer, thereby increasing the migration prevention effect. be able to.
  • the stent according to the second modification shown in FIG. 7 has the first hooking portions 24 and 44 pulled in the axial direction D2 as shown in FIG. It is accommodated in an extended state. Further, when the stent delivery system 50 releases the stent to the indwelling position, the accommodated stent is axially moved by the push ring 69 against the axial force D2 caused by the frictional force generated between the stent delivery system 50 and the outer sheath 66. By being pushed by D2, it is exposed from the outer sheath 66.
  • the first hooking parts 24 and 44 are not connected in the circumferential direction and are independent, when pushed in the axial direction D2 from the front end parts 24a and 44a by the push ring 69, they are crushed in the axial direction D2. There may be concerns. However, in the stent according to the second modification example, as shown in FIG. 7, since the portion P where the second portions 24cb and 44cb overlap in the axial direction D2 is formed, the force in the axial direction D2 at the time of discharge is the first. The hooking portions 24 and 44 can be received and can be smoothly exposed from the outer sheath 66.
  • the first hooking parts 24 and 44 as shown in FIG. 7 may be provided at both end parts of the main body part 12, or may be provided only at one end part. However, when it is provided only at one end, the side where the first hooking parts 24 and 44 are provided at the time of release may be accommodated in the transport mechanism 52 so that the stent is pushed by the push ring 69. preferable.

Abstract

Provided is luminal organ bypass stent having a migration-preventive function. A luminal organ bypass stent (11) characterized by having: a slender cylindrical body (12) connected in the circumferential direction; and a plurality of first hooking parts (14) having a curved shape curving to the outside of the body (12) along the longitudinal direction from proximal-end parts (14b) thereof connected to a first end part (R) which is one of both end parts in the axial direction (D2) toward free distal-end parts (14a), the first hooking parts (14) being independent and not connected to each other in the circumferential direction; intermediate parts (14c) between the distal-end parts (14a) and the proximal-end parts (14b) in the first hooking parts (14) having a plurality of first portions, the length of which in a width direction orthogonal to the longitudinal direction being a first length, and at least one second portion, both sides of which in the longitudinal direction being interposed in the first portions, and the length thereof in the width direction being a second length greater than the first length.

Description

管腔臓器間バイパス用ステント及び管腔臓器間バイパス用ステントを含むステントデリバリーシステムStent for lumen-organ bypass and stent delivery system including stent for lumen-organ bypass
 本発明は、管腔臓器間バイパス用ステント及びこれを体内の所定位置まで搬送するステントデリバリーシステムに関する。 The present invention relates to a luminal organ bypass stent and a stent delivery system for delivering the stent to a predetermined position in the body.
 近年、切除不能の悪性胆道狭窄又は閉塞症例で、胆道ドレナージを必要とするもののうち、経十二指腸乳頭的アプローチが不可能な場合等において、超音波内視鏡ガイド下胆道ドレナージ(EUS-BD)を施行した報告がある。EUS-BDは、超音波内視鏡を胃又は十二指腸に挿入し、超音波画像をリアルタイムに観察しながら、胃壁又は十二指腸壁から穿刺針で胆管又は胆嚢を穿刺し、ガイドワイヤーを胆管又は胆嚢に挿入し、胃壁又は十二指腸壁と胆管又は胆嚢とを架け渡すようにバイパス用ステントを挿入・留置する手技である。この手技により、体内にステントを埋め込む形で胆管ドレナージが可能となる。 In recent years, patients with unresectable malignant biliary strictures or obstructions who require biliary drainage and are unable to undergo transduodenal papilla approach, etc., have undergone ultrasound endoscopic guided biliary drainage (EUS-BD). There are reports of enforcement. EUS-BD inserts an ultrasound endoscope into the stomach or duodenum, punctures the bile duct or gallbladder with a puncture needle from the stomach wall or duodenum wall while observing the ultrasound image in real time, and guides the guide wire into the bile duct or gallbladder. This is a procedure for inserting and placing a bypass stent so as to bridge the stomach wall or duodenal wall and the bile duct or gallbladder. This procedure enables bile duct drainage in the form of implanting a stent in the body.
 EUS-BDに用いられるステントとしては、金属製のステント基材の表面をポリマー製フィルムからなるカバー材で被覆してなるカバードステントが挙げられる。また、特にEUS-BDに好適に用いられるカバードステントとして、マイグレーションを防止したり、内臓壁を傷付けることを防止したりするためのフッキング部を有するものが提案されている(特許文献1参照)。 Examples of the stent used in EUS-BD include a covered stent obtained by coating the surface of a metal stent substrate with a cover material made of a polymer film. In particular, a covered stent that is suitably used for EUS-BD has been proposed that has a hooking portion for preventing migration and preventing damage to a visceral wall (see Patent Document 1).
特開2015-66221号公報Japanese Patent Laying-Open No. 2015-66221
 しかしながら、胃などの消化管は大きく変形し得るため、管腔臓器と他の管腔臓器とをバイパス接続するための管腔臓器間バイパス用ステントに対しては、管腔臓器の変形に耐えてバイパスが維持されるように、マイグレーションの防止機能をさらに高めることが求められている。 However, since the digestive tract such as the stomach can be greatly deformed, it is resistant to the deformation of the luminal organ with respect to the stent for bypassing the luminal organ for bypass connection between the luminal organ and other luminal organs. It is required to further improve the migration prevention function so that the bypass is maintained.
 本発明は、このような実状に鑑みてなされ、その目的は、マイグレーションの防止機能を有する管腔臓器間バイパス用ステント及びこれを含むステントデリバリーシステムを提供することである。 The present invention has been made in view of such a situation, and an object of the present invention is to provide a lumen-organ bypass stent having a migration preventing function and a stent delivery system including the same.
 上記目的を達成するために、本発明に係る管腔臓器間バイパス用ステントは、
 管腔臓器と他の管腔臓器とをバイパス接続するための管腔臓器間バイパス用ステントであって、
 周方向に繋がっている細長い筒状の本体部と、 
 前記本体部の軸方向の両端部のうちの一方である第1端部に接続する基端部から、自由端である先端部へ向かう長手方向に沿って、前記本体部の外側へ湾曲する湾曲形状を有しており、前記周方向には互いに繋がっておらず独立している複数の第1フッキング部と、を有し、
 前記第1フッキング部において前記先端部と前記基端部との間にある中間部は、前記長手方向に直交する幅方向の長さが第1長さである複数の第1部分と、前記第1部分に前記長手方向の両側を挟まれており、前記幅方向の長さが前記第1長さより長い第2長さである少なくとも1つの第2部分と、を有することを特徴とする。
In order to achieve the above object, a stent for bypass between luminal organs according to the present invention,
A stent for bypassing a luminal organ for bypassing a luminal organ and another luminal organ,
An elongated cylindrical body connected in the circumferential direction;
A curve that curves to the outside of the main body portion along a longitudinal direction from a proximal end portion connected to a first end portion that is one of both axial end portions of the main body portion toward a distal end portion that is a free end. A plurality of first hooking portions that have a shape and are not connected to each other in the circumferential direction;
In the first hooking portion, an intermediate portion between the distal end portion and the proximal end portion includes a plurality of first portions having a first length in the width direction orthogonal to the longitudinal direction, and the first portion And at least one second portion having a second length that is longer than the first length and sandwiched on both sides in the longitudinal direction by one portion.
 本発明に係る管腔臓器間バイパス用ステントは、第1フッキング部の中間部に、幅方向の長さが異なる第1部分と第2部分とを有するため、特に幅方向の長さが長い第2部分や、第1部分と第2部分との境界部が、ステントが留置位置から移動することを妨げるアンカーとして機能する。したがって、このような管腔臓器間バイパス用ステントは、マイグレーションを効果的に防止することができる。 The interluminal organ bypass stent according to the present invention has a first portion and a second portion having different lengths in the width direction at the intermediate portion of the first hooking portion. The two portions or the boundary between the first portion and the second portion functions as an anchor that prevents the stent from moving from the indwelling position. Therefore, such a lumen-organ bypass stent can effectively prevent migration.
 また、たとえば、前記複数の前記第1フッキング部には、前記周方向に隣接して配置されており、互いに形状の異なる第1タイプの前記第1フッキング部と、第2タイプの前記第1フッキング部とが含まれていてもよく、
 前記長手方向の位置に関して、前記第1タイプの前記第1フッキング部において前記第1部分が配置されている位置に、前記第2タイプの前記第1フッキング部では前記第2部分が配置されていてもよい。
In addition, for example, the plurality of first hooking portions are arranged adjacent to each other in the circumferential direction, and the first type of the first hooking portion and the second type of the first hooking are different in shape from each other. Part may be included,
Regarding the position in the longitudinal direction, the second part is disposed in the first hooking part of the second type at the position where the first part is disposed in the first hooking part of the first type. Also good.
 第1フッキング部における第1部分と第2部分との長手方向の位置が入れ替わっている第1タイプと第2タイプとを、周方向に隣接するように配置している管腔臓器間バイパス用ステントは、第2部分を、互いに幅方向に重複することなく密に形成してあるので、第2部分の第2長さを長くしても、ステントデリバリーシステムに収容される際において、それぞれの第2部分が互いに邪魔になりにくく、第2長さをより長いものとすることによって、より良好なマイグレーション防止機能を有するものとすることができる。また、ステントデリバリーシステムから放出する際における押し出し易さも良好なものとなる。 Stent for bypassing a luminal organ in which the first type and the second type in which the positions in the longitudinal direction of the first part and the second part in the first hooking part are interchanged are arranged adjacent to each other in the circumferential direction Since the second portions are densely formed without overlapping each other in the width direction, even when the second length of the second portion is increased, each of the second portions is accommodated in the stent delivery system. The two portions are less likely to interfere with each other, and by making the second length longer, it is possible to have a better migration prevention function. In addition, the ease of extrusion when releasing from the stent delivery system is also good.
 また、たとえば前記基端部から前記先端部に向けて、前記軸方向に対する角度が90°を超えて変化するように湾曲していてもよい。 Also, for example, the base end portion may be curved toward the tip end portion so that an angle with respect to the axial direction changes over 90 °.
 第1フッキング部の湾曲形状は、特に限定されないが、基端部から先端部に向けて、軸方向に対する角度が90°を超えて変化するように湾曲していることにより、第1フッキング部の湾曲形状が引き延ばされる際に生じる抵抗力がより大きくなる。そのため、このような第1フッキング部を有する管腔臓器間バイパス用ステントは、さらに良好なマイグレーション防止効果を奏する。 The curved shape of the first hooking portion is not particularly limited, but the first hooking portion is curved so that the angle with respect to the axial direction changes beyond 90 ° from the proximal end portion toward the distal end portion. The resistance force that occurs when the curved shape is stretched is increased. Therefore, the luminal-organ bypass stent having such a first hooking portion has an even better migration preventing effect.
 また、たとえば、前記第1フッキング部において、前記中間部における前記基端部側の一部は、前記軸方向に関して前記第1端部よりも外側に位置してもよく、
 前記第1フッキング部において、前記中間部における前記先端部側の他の一部又は前記先端部は、前記軸方向に関して前記第1端部よりも内側に位置してもよい。
Further, for example, in the first hooking portion, a part of the intermediate portion on the base end portion side may be located outside the first end portion with respect to the axial direction.
In the first hooking portion, the other part of the intermediate portion on the tip portion side or the tip portion may be located inside the first end portion with respect to the axial direction.
 このような第1フッキング部を有する管腔臓器間バイパス用ステントでは、第1フッキング部が管腔臓器の内壁に触れることによって、本体部の端部を管腔臓器の内部側に押し込むような力が加わるので、さらなるマイグレーション防止効果を奏することができる。 In such a lumen-organ bypass stent having the first hooking portion, the first hooking portion touches the inner wall of the hollow organ, and thus the force that pushes the end of the main body into the inner side of the hollow organ. Therefore, the effect of preventing further migration can be achieved.
 また、たとえば、本発明にかかる管腔臓器間バイパス用ステントは、前記本体部の前記両端部のうちの他方である第2端部に接続する基端部から、自由端である先端部へ向かう長手方向に沿って、前記本体部の外側へ湾曲する湾曲形状を有しており、前記周方向には互いに繋がっておらず独立している複数の第2フッキング部をさらに有してもよく、
 前記第2フッキング部において前記先端部と前記基端部との間にある中間部は、前記長手方向に直交する幅方向の長さが第1長さである複数の第1部分と、前記第1部分に前記長手方向の両側を挟まれており、前記幅方向の長さが前記第1長さより長い第2長さである少なくとも1つの第2部分と、を有してもよい。
In addition, for example, the interluminal organ bypass stent according to the present invention is directed from the proximal end portion connected to the second end portion which is the other of the both end portions of the main body portion to the distal end portion which is a free end. It has a curved shape that curves to the outside of the main body portion along the longitudinal direction, and may further include a plurality of second hooking portions that are independent from each other in the circumferential direction,
In the second hooking portion, an intermediate portion between the distal end portion and the proximal end portion includes a plurality of first portions whose length in the width direction orthogonal to the longitudinal direction is a first length, and the first portion One part may include at least one second part sandwiched on both sides in the longitudinal direction and having a second length that is longer than the first length in the width direction.
 このような管腔臓器間バイパス用ステントは、本体部の両端部に接続される第1フッキング部と第2フッキング部とが、いずれも留置位置からのずれを防止するアンカーとして作用することにより、マイグレーションをより効果的に防止することができる。 In such a lumen organ bypass stent, the first hooking portion and the second hooking portion connected to both ends of the main body portion both act as anchors that prevent deviation from the indwelling position, Migration can be prevented more effectively.
 また、たとえば前記第2フッキング部は、前記基端部から前記先端部に向けて、前記軸方向に対する角度が90°を超えて変化していてもよい。 Further, for example, the second hooking portion may have an angle with respect to the axial direction exceeding 90 ° from the base end portion toward the tip end portion.
 第2フッキング部が軸方向に対して90°を超えて湾曲していることにより、第2フッキング部の湾曲形状が引き延ばされる際に生じる抵抗力がより大きくなるため、このような第2フッキング部を有する管腔臓器間バイパス用ステントは、より良好なマイグレーション防止効果を奏する。 Since the second hooking portion is curved to exceed 90 ° with respect to the axial direction, a resistance force generated when the curved shape of the second hooking portion is extended becomes larger. The stent for bypassing a luminal organ having a portion has a better migration preventing effect.
 また、たとえば、前記第2フッキング部において、前記中間部における前記基端部側の一部は、前記軸方向に関して前記第1端部よりも外側に位置してもよく、
 前記第2フッキング部において、前記中間部における前記先端部側の他の一部又は前記先端部は、前記軸方向に関して前記第1端部よりも内側に位置してもよい。
Further, for example, in the second hooking portion, a part of the base end portion side in the intermediate portion may be located outside the first end portion with respect to the axial direction.
In the second hooking portion, the other part of the intermediate portion on the tip portion side or the tip portion may be located inside the first end portion with respect to the axial direction.
 このような第2フッキング部を有する管腔臓器間バイパス用ステントでは、第2フッキング部が管腔臓器の内壁に触れることによって、本体部の端部を管腔臓器の内部側に押し込むような力が加わるので、さらなるマイグレーション防止効果を奏することができる。 In such a lumen-organ bypass stent having the second hooking portion, the second hooking portion touches the inner wall of the hollow organ, and thereby the force that pushes the end of the main body into the inner side of the hollow organ. Therefore, the effect of preventing further migration can be achieved.
 本発明に係るステントデリバリーシステムは、上記いずれかに記載の管腔臓器間バイパス用ステントと、
 前記管腔臓器間バイパス用ステントを体内の所定の位置に搬送する搬送機構と、を有する。
A stent delivery system according to the present invention includes any one of the above-described stents for bypassing a luminal organ,
A delivery mechanism for delivering the lumen-organ bypass stent to a predetermined position in the body.
図1は、本発明に係るステントデリバリーシステムの一例を表す概念図である。FIG. 1 is a conceptual diagram showing an example of a stent delivery system according to the present invention. 図2は、本発明に係る管腔臓器間バイパス用ステントの一例を表す外観図である。FIG. 2 is an external view showing an example of a luminal organ bypass stent according to the present invention. 図3は、図2に示す管腔臓器間バイパス用ステントにおける本体部の断面図である。FIG. 3 is a cross-sectional view of the main body portion of the luminal organ bypass stent shown in FIG. 図4は、図2に示す管腔臓器間バイパス用ステントにおけるフレーム部及びフレーム部と一体に形成された第1及び第2フッキング部を表す部分展開図である。FIG. 4 is a partial development view showing the frame portion and the first and second hooking portions formed integrally with the frame portion in the lumen-organ bypass stent shown in FIG. 図5は、図4に示す管腔臓器間バイパス用ステントの部分拡大図である。FIG. 5 is a partially enlarged view of the lumen-organ bypass stent shown in FIG. 図6は、第1変形例に係る管腔臓器間バイパス用ステントの部分拡大図である。FIG. 6 is a partially enlarged view of a luminal organ bypass stent according to a first modification. 図7は、第2変形例に係る管腔臓器間バイパス用ステントの部分拡大図である。FIG. 7 is a partially enlarged view of a lumen-organ bypass stent according to a second modification.
 本発明の管腔臓器間バイパス用ステント及びこれを含むステントデリバリーシステムについて、図1~図7に示す実施形態及びその変形例を参照して説明する。 The lumen-organ bypass stent of the present invention and a stent delivery system including the same will be described with reference to the embodiment shown in FIGS.
 図1は本発明の一実施形態に係るステントデリバリーシステム50の外観図であり、図1(a)は管腔臓器間バイパス用ステント11(以下、単に「ステント11」と省略する場合がある。)を収容した第1状態のステントデリバリーシステム50を表しており、図1(b)はステント11を放出する第2状態のステントデリバリーシステム50の遠位端部分を表している。なお、ステントデリバリーシステム50の説明においては、操作部60が配置される近位端から先端チップ62が配置される遠位端まで、ステントデリバリーシステム50が延在する方向を軸方向D1として、説明を行う。 FIG. 1 is an external view of a stent delivery system 50 according to an embodiment of the present invention, and FIG. 1A may be abbreviated as “stent 11” (hereinafter simply referred to as “stent 11”). ) Is shown, and FIG. 1 (b) shows the distal end portion of the second state stent delivery system 50 that releases the stent 11. In the description of the stent delivery system 50, the direction in which the stent delivery system 50 extends from the proximal end where the operation unit 60 is disposed to the distal end where the tip tip 62 is disposed is defined as the axial direction D1. I do.
 図1に示すように、ステントデリバリーシステム50は、ステント11と、ステント11を体内の所定の位置に搬送する搬送機構52とで構成される。搬送機構52は、操作部60、最外管64、アウターシース66、インナーシャフト68及び先端チップ62等を有する。ステントデリバリーシステム50の全長は、ステント11の留置位置や搬送経路等によって異なるが、たとえば300~2500mm程度である。 1, the stent delivery system 50 includes a stent 11 and a transport mechanism 52 that transports the stent 11 to a predetermined position in the body. The transport mechanism 52 includes an operation unit 60, an outermost pipe 64, an outer sheath 66, an inner shaft 68, a tip end 62, and the like. The total length of the stent delivery system 50 is, for example, about 300 to 2500 mm, although it varies depending on the placement position of the stent 11, the transport route, and the like.
 図1(a)に示すように、ステント11は、ステントデリバリーシステム50の遠位端近傍に収容されている。ステントデリバリーシステム50の操作者は、図1(a)に示す第1状態でステント11を体内の留置位置まで搬送した後、ステントデリバリーシステム50を図1(b)に示す第2状態とすることにより、ステント11を放出して体内の所定の位置に留置する。 As shown in FIG. 1A, the stent 11 is accommodated in the vicinity of the distal end of the stent delivery system 50. The operator of the stent delivery system 50 transfers the stent 11 to the indwelling position in the body in the first state shown in FIG. 1 (a), and then sets the stent delivery system 50 in the second state shown in FIG. 1 (b). Thus, the stent 11 is released and placed at a predetermined position in the body.
 図1(a)及び図1(b)に示すように、インナーシャフト68は、ステントデリバリーシステム50の近位端に備えられる操作部60から、ステントデリバリーシステム50の遠位端に備えられる先端チップ62まで、軸方向D1に延びている。図1(a)に示す第1の状態において、インナーシャフト68は、アウターシース66及び操作部60のハウジング61等の内部に収容されている。 As shown in FIGS. 1A and 1B, the inner shaft 68 is provided with a tip tip provided at the distal end of the stent delivery system 50 from the operation unit 60 provided at the proximal end of the stent delivery system 50. Up to 62, it extends in the axial direction D1. In the first state shown in FIG. 1A, the inner shaft 68 is accommodated inside the outer sheath 66 and the housing 61 of the operation unit 60.
 図1(b)に示すように、インナーシャフト68は、遠位端近傍に、他の部分より外径が小さい小径部を有する。アウターシース66が近位端側に移動した第2の状態では、遠位端にある小径部が露出する。インナーシャフト68の内部には、ガイドワイヤーを通すためのガイドワイヤルーメンが形成されている。 As shown in FIG. 1 (b), the inner shaft 68 has a small-diameter portion having a smaller outer diameter than other portions in the vicinity of the distal end. In the second state where the outer sheath 66 has moved to the proximal end side, the small diameter portion at the distal end is exposed. Inside the inner shaft 68, a guide wire lumen for passing the guide wire is formed.
 インナーシャフト68の遠位端には、先端チップ62が設けられており、先端チップ62には、インナーシャフト68のガイドワイヤルーメンに連通する貫通孔が形成されている。先端チップ62は樹脂等で作製されており、管腔臓器の内壁に接触した際に、これを傷つけることを防止できるように、丸みを帯びた外形状を有している。 A distal tip 62 is provided at the distal end of the inner shaft 68, and a through hole communicating with the guide wire lumen of the inner shaft 68 is formed in the distal tip 62. The tip 62 is made of resin or the like, and has a rounded outer shape so that it can be prevented from being damaged when it comes into contact with the inner wall of the luminal organ.
 アウターシース66は、図1(a)に示す第1の状態から、図1(b)に示す第2の状態へ、インナーシャフト68に対して軸方向D1へ相対移動可能である。アウターシース66の近位端は、操作部60におけるハウジング61の内部に収容されている。操作部60は、ハウジング61に取り付けられた操作レバー63の操作に連動して、アウターシース66をインナーシャフト68に対して、軸方向D1の一方である近位端側に相対移動させる。これにより、ステントデリバリーシステム50は、アウターシース66がインナーシャフト68の小径部を覆う第1の状態から(図1(a))、インナーシャフト68の小径部及びステント11を露出させる第2の状態へ(図1(b))変化する。なお、操作部60の近傍には、アウターシース66の外周をさらに覆う最外管64が設けられている。操作者がアウターシース66を直接に握ると、操作部60によるアウターシース66の移動が妨げられるおそれがあるが、最外管64がアウターシース66を覆うことにより、そのような問題を防止できる。 The outer sheath 66 is movable relative to the inner shaft 68 in the axial direction D1 from the first state shown in FIG. 1A to the second state shown in FIG. A proximal end of the outer sheath 66 is accommodated in the housing 61 of the operation unit 60. The operation unit 60 moves the outer sheath 66 relative to the inner shaft 68 toward the proximal end side in the axial direction D1 in conjunction with the operation of the operation lever 63 attached to the housing 61. Thereby, the stent delivery system 50 is in the second state in which the outer sheath 66 exposes the small diameter portion of the inner shaft 68 and the stent 11 from the first state in which the outer sheath 66 covers the small diameter portion of the inner shaft 68 (FIG. 1A). (FIG. 1 (b)). An outermost pipe 64 that further covers the outer periphery of the outer sheath 66 is provided in the vicinity of the operation unit 60. If the operator directly grips the outer sheath 66, the movement of the outer sheath 66 by the operation unit 60 may be hindered. However, the outermost tube 64 covers the outer sheath 66, so that such a problem can be prevented.
 搬送機構52の最外管64、アウターシース66及びインナーシャフト68は、たとえば、可撓性を有する樹脂製のチューブ等で構成される。また、アウターシース66に用いられる樹脂チューブの内部には、金属の線材が埋め込まれていてもよい。なお、インナーシャフト68における小径部の近位端側には、ステント11の放出時にステント11を軸方向D1に押すプッシュリング69(図1(b)参照)が設けられていてもよく、そのプッシュリング69は、X線不透過材料で構成されていてもよい。また、搬送機構52における先端チップ62や操作部60の材料は特に限定されないが、たとえば、樹脂を成形又は加工したものを用いることができる。 The outermost pipe 64, the outer sheath 66, and the inner shaft 68 of the transport mechanism 52 are made of, for example, a flexible resin tube. In addition, a metal wire may be embedded in the resin tube used for the outer sheath 66. A push ring 69 (see FIG. 1B) that pushes the stent 11 in the axial direction D1 when the stent 11 is released may be provided on the proximal end side of the small diameter portion of the inner shaft 68. The ring 69 may be made of a radiopaque material. Moreover, the material of the front-end | tip chip | tip 62 and the operation part 60 in the conveyance mechanism 52 is not specifically limited, For example, what shape | molded or processed resin can be used.
 図2は、ステントデリバリーシステム50に収容されるステント11の外観図であり、ステント11が径方向に拡張した状態を示している。ステント11は、管腔臓器と他の管腔臓器とをバイパス接続するための管腔臓器間バイパス用ステントとして、超音波内視鏡ガイド下経胆道ドレナージ(EUS-BD)に用いる管腔臓器間バイパス用ステント、すなわち、胃又は十二指腸と胆管又は胆嚢とをバイパス接続するバイパス用ステントである。また、ステント11は、径方向に圧縮力を加えると弾性によって径方向に収縮し、その圧縮力が解除されると径方向に拡張する自己拡張型のカバードステントである。ただし、本発明の管腔臓器間バイパス用ステントはこれに限定されず、バルーン拡張型のカバードステントであってもよく、さらには径方向に拡張しないチューブステント等のステントであってもよい。 FIG. 2 is an external view of the stent 11 accommodated in the stent delivery system 50, and shows a state in which the stent 11 is expanded in the radial direction. The stent 11 is used as an inter-luminal organ bypass stent for bypass-connecting a luminal organ to another luminal organ, and is used for ultrasonic endoscopic-guided transbiliary drainage (EUS-BD). A bypass stent, that is, a bypass stent that bypasses the stomach or duodenum and the bile duct or gallbladder. The stent 11 is a self-expanding covered stent that contracts in the radial direction due to elasticity when a compressive force is applied in the radial direction and expands in the radial direction when the compressive force is released. However, the lumen-organ bypass stent of the present invention is not limited to this, and may be a balloon-expanded covered stent, or may be a stent such as a tube stent that is not radially expanded.
 図2に示すように、ステント11は、細長い略筒状の本体部12と、本体部12の両端部のうちの一方である第1端部(図2において右端)Rに設けられた複数の第1フッキング部14と、本体部12の両端部のうちの他方である第2端部(図2において左端)Lに設けられた複数の第2フッキング部15とを有する。 As shown in FIG. 2, the stent 11 includes an elongated substantially cylindrical main body portion 12 and a plurality of first end portions (right end in FIG. 2) R that are one of both end portions of the main body portion 12. The first hooking portion 14 and a plurality of second hooking portions 15 provided at the second end portion (left end in FIG. 2) L which is the other of the both end portions of the main body portion 12.
 本体部12は、筒状のフレーム部13と、フレーム部13の外周を覆う被覆フィルム部12aとを有する。図4は、図2に示すステント11におけるフレーム部13及びフレーム部13と一体に形成された第1及び第2フッキング部14、15を表す部分展開図であり、ステント11を径方向に最も収縮させたときの状態を示している。図4に示すように、フレーム部13は、金属製(又は樹脂製)の線状部材であるストラット13a及びブリッジ13bにより形成されている。ここでフレーム部13は線材を編込んで形成してもよいが、図4に示すように、チューブ状若しくはパイプ状の母材にレーザー加工等を行ってストラット13a及びブリッジ13bを形成した、いわゆるレーザーカットタイプであることが好ましい。フレーム部13がレーザーカットタイプであれば、フレーム部13が径方向に拡張するとき、フレーム部13の軸方向D2の長さの縮みが抑制され、ステント11を意図した位置に留置しやすくなる。フレーム部13を構成するストラット13a及びブリッジ13bの断面形状は四角形状や円形状とすることができる。なお、図2及び図4に示すステント11の説明では、筒状の本体部12の中心軸Cが延びる方向を、ステント11の説明における軸方向D2とする。図1(a)に示すように、ステント11は、本体部12の軸方向D2が、ステントデリバリーシステム50の軸方向D1に一致するように、搬送機構52に収容される。 The main body portion 12 includes a cylindrical frame portion 13 and a covering film portion 12 a that covers the outer periphery of the frame portion 13. FIG. 4 is a partial development view showing the first and second hooking portions 14 and 15 formed integrally with the frame portion 13 and the frame portion 13 in the stent 11 shown in FIG. 2, and the stent 11 is most contracted in the radial direction. The state at the time of letting it be shown is shown. As shown in FIG. 4, the frame portion 13 is formed by struts 13a and bridges 13b, which are metal (or resin) linear members. Here, the frame portion 13 may be formed by knitting a wire, but as shown in FIG. 4, a so-called strut 13a and a bridge 13b are formed by performing laser processing or the like on a tube-like or pipe-like base material. A laser cut type is preferred. If the frame portion 13 is a laser cut type, when the frame portion 13 expands in the radial direction, contraction of the length of the frame portion 13 in the axial direction D2 is suppressed, and the stent 11 can be easily placed at the intended position. The cross-sectional shapes of the struts 13a and the bridges 13b constituting the frame portion 13 can be a square shape or a circular shape. In the description of the stent 11 shown in FIGS. 2 and 4, the direction in which the central axis C of the cylindrical main body 12 extends is the axial direction D <b> 2 in the description of the stent 11. As shown in FIG. 1A, the stent 11 is housed in the transport mechanism 52 so that the axial direction D2 of the main body 12 matches the axial direction D1 of the stent delivery system 50.
 フレーム部13は、図2にも示されているように、ジグザグ円環状の複数のストラット13aと、隣接するストラット13a間を接続するブリッジ13bとを有する。ストラット13aは、フレーム部13の周方向に沿って三角波状に連続し、円環状に繋がっている。ただし、図4に示すように、フレーム部13が最も収縮している状態(レーザーカット後の状態)においては、ストラット13aは、S字状に蛇行しながら、周方向に繋がっている。 As shown in FIG. 2, the frame unit 13 includes a plurality of zigzag annular struts 13 a and bridges 13 b that connect adjacent struts 13 a. The struts 13a are continuous in a triangular wave shape along the circumferential direction of the frame portion 13, and are connected in an annular shape. However, as shown in FIG. 4, in a state where the frame portion 13 is most contracted (a state after laser cutting), the struts 13 a are connected in the circumferential direction while meandering in an S shape.
 図2及び図4に示すように、ブリッジ13bは、隣接するストラット13aにおける三角波の頂点又は蛇行形状のカーブ部分の一部を、軸方向D2に接続している。このようにして複数のストラット13aが接続されることにより、筒状のフレーム部13が構成されている。隣接する2つのストラット13aを接続するブリッジ13bは、略均等な間隔で配置されるが、隣接する2つのストラット13aを接続するブリッジ13bの位置は、軸方向D2に並んで形成されることはなく、周方向にずれている。 As shown in FIGS. 2 and 4, the bridge 13b connects the apex of the triangular wave or a part of the meandering curve portion in the adjacent strut 13a in the axial direction D2. Thus, the cylindrical frame part 13 is comprised by connecting the some strut 13a. The bridges 13b connecting the two adjacent struts 13a are arranged at substantially equal intervals, but the positions of the bridges 13b connecting the two adjacent struts 13a are not formed side by side in the axial direction D2. , Shifted in the circumferential direction.
 図3は、図2に示すステント11の断面図である。図3に示すように、フレーム部13の表面はコーティング膜12cで覆われており、また、コーティング膜12cは、隣接するストラット13aの間を埋めるように広がっており、フレーム部13の外周面を被覆している。コーティング膜12cによって覆われたフレーム部13の外周は、第1のポリマーフィルム12aaと第2のポリマーフィルム12abとを含む被覆フィルム部12aによって覆われている。 FIG. 3 is a cross-sectional view of the stent 11 shown in FIG. As shown in FIG. 3, the surface of the frame portion 13 is covered with a coating film 12 c, and the coating film 12 c extends so as to fill between adjacent struts 13 a, and the outer peripheral surface of the frame portion 13 is covered. It is covered. The outer periphery of the frame portion 13 covered with the coating film 12c is covered with a covering film portion 12a including a first polymer film 12aa and a second polymer film 12ab.
 コーティング膜12cによってフレーム部13を被覆することによって、ステント11(本体部12)の内周面であるステント内周表面12bを、平滑にすることができる。ステント内周表面12bを平滑にすることで、ステント11を体内に留置した場合に、ステント内周表面12bに老廃物が堆積し難くなり、感染症等が防止される。 By covering the frame portion 13 with the coating film 12c, the stent inner peripheral surface 12b, which is the inner peripheral surface of the stent 11 (main body portion 12), can be smoothed. By smoothing the inner peripheral surface 12b of the stent, when the stent 11 is placed in the body, it is difficult for waste to accumulate on the inner peripheral surface 12b of the stent, and infections and the like are prevented.
 コーティング膜12cの材料としては、エラストマーや樹脂等のポリマーが用いられるが、その中でも、有機溶媒に溶解し毒性の少ないものが好ましい。コーティング膜12cに用いることができるポリマーとしては、たとえば非生体分解性ポリマーや生体分解性ポリマーを使用できるが、生体内で容易に分解されない非生体分解性ポリマーを用いることが好ましく、非生体分解性ポリマーの中でも、ポリウレタン又はシリコーン樹脂を用いることが特に好ましい。なお、コーティング膜12cを構成するポリマーには、必要に応じて、抗がん剤や抗血栓剤などの薬剤や、老化防止剤などの添加剤を配合してもよい。 As the material of the coating film 12c, polymers such as elastomers and resins are used, and among them, a material that dissolves in an organic solvent and has little toxicity is preferable. As the polymer that can be used for the coating film 12c, for example, a non-biodegradable polymer or a biodegradable polymer can be used. However, it is preferable to use a non-biodegradable polymer that is not easily decomposed in a living body. Among the polymers, it is particularly preferable to use polyurethane or silicone resin. In addition, you may mix | blend additives, such as chemical | medical agents, such as an anticancer agent and an antithrombotic agent, and anti-aging agent, with the polymer which comprises the coating film 12c as needed.
 フレーム部13の表面にコーティング膜12cを形成する方法としては、特に限定されないが、フレーム部13を樹脂溶液に浸漬させた後、乾燥させる方法が好適である。 The method of forming the coating film 12c on the surface of the frame part 13 is not particularly limited, but a method of drying the frame part 13 after immersing the frame part 13 in a resin solution is suitable.
 フレーム部13の外周を覆う被覆フィルム部12aは、第1のポリマーフィルム12aaと第2のポリマーフィルム12abを含む。第1のポリマーフィルム12aaは、フレーム部13と第2のポリマーフィルム12abの間に配置されており、フレーム部13の外周を被覆する。 The covering film part 12a covering the outer periphery of the frame part 13 includes a first polymer film 12aa and a second polymer film 12ab. The first polymer film 12aa is disposed between the frame portion 13 and the second polymer film 12ab, and covers the outer periphery of the frame portion 13.
 第1のポリマーフィルム12aaの厚さは、第1のポリマーフィルム12aa全体の平均値として、4~20μmとすることが好ましい。第1のポリマーフィルム12aaが厚すぎると、ステント11の柔軟性が不足するおそれがある。また、第1のポリマーフィルム12aaが薄すぎると、第2のポリマーフィルム12abを、フレーム部13による穿孔等から保護できなくなるおそれがある。 The thickness of the first polymer film 12aa is preferably 4 to 20 μm as an average value of the entire first polymer film 12aa. If the first polymer film 12aa is too thick, the flexibility of the stent 11 may be insufficient. In addition, if the first polymer film 12aa is too thin, the second polymer film 12ab may not be protected from perforation by the frame portion 13 or the like.
 第1のポリマーフィルム12aaは、フレーム部13の外周を、1周以上1周半未満周回するように、フレーム部13に巻きつけられている。第1のポリマーフィルム12aaの巻回数を1周~1周半とすることによって、第2のポリマーフィルム12abをフレーム部13による穿孔等から保護しつつ、本体部12の柔軟性が不足することを防止することができる。 The first polymer film 12aa is wound around the frame portion 13 so as to circulate the outer periphery of the frame portion 13 one or more times and less than one and a half times. By setting the number of windings of the first polymer film 12aa to 1 to 1 and a half, the second polymer film 12ab is protected from perforation by the frame part 13 and the flexibility of the main body part 12 is insufficient. Can be prevented.
 第2のポリマーフィルム12abは、第1のポリマーフィルム12aaの外周を、複数回周回するように、第1のポリマーフィルム12aaに巻き付けられている。第2のポリマーフィルム12abの巻回数を複数周とすることにより、ステント11の内部を通る胆汁等の消化液や消化された食物等が第1のポリマーフィルム12aaの外側まで漏出したとしても、それ以上の漏出を第2のポリマーフィルム12abによって確実に防止することができる。 The second polymer film 12ab is wound around the first polymer film 12aa so as to circulate the outer periphery of the first polymer film 12aa a plurality of times. By setting the number of windings of the second polymer film 12ab to a plurality of turns, even if digestive fluid such as bile passing through the inside of the stent 11 or digested food leaks to the outside of the first polymer film 12aa, The above leakage can be reliably prevented by the second polymer film 12ab.
 第1のポリマーフィルム12aa及び第2のポリマーフィルム12abの材料としては、エラストマーや樹脂等のポリマーが用いられるが、その中でも、有機溶媒に溶解し毒性の少ないものが好ましい。また、ステント11の本体部12の柔軟性を確保しながら、第2のポリマーフィルム12abをフレーム部13による穿孔等から保護する観点から、第1のポリマーフィルム12aaの材料として、第2のポリマーフィルム12abの材料であるポリマーに比べて高い強度を有するポリマーを用いることが好ましい。 As the material of the first polymer film 12aa and the second polymer film 12ab, polymers such as elastomers and resins are used, and among them, those that dissolve in an organic solvent and have low toxicity are preferable. Also, from the viewpoint of protecting the second polymer film 12ab from perforation by the frame portion 13 while ensuring the flexibility of the main body portion 12 of the stent 11, the second polymer film is used as the material of the first polymer film 12aa. It is preferable to use a polymer having higher strength than a polymer that is a material of 12ab.
 図2に示すように、本体部12の全長Hは、バイパス接続すべき管腔臓器間の距離に応じて決定されるが、10mm~200mmとすることができ、40mm~120mmとすることが好ましい。また、本体部12の拡張時(外力が働いていないとき)の外径Dは、バイパス接続すべき管腔臓器の種類や大きさ等に応じて決定されるが、φ2mm~φ20mmとすることができ、φ4mm~φ15mmとすることが好ましく、φ6mm~φ10mmとすることがさらに好ましい。本体部12の収縮時(ステントデリバリーシステム収容時)の外径は、拡張時の外径に対して、数分の1程度である。 As shown in FIG. 2, the total length H of the main body 12 is determined according to the distance between the luminal organs to be bypassed, but can be 10 mm to 200 mm, and preferably 40 mm to 120 mm. . Further, the outer diameter D of the main body 12 when it is expanded (when no external force is applied) is determined according to the type and size of the luminal organ to be bypassed, but may be set to φ2 mm to φ20 mm. It is preferable to set it to φ4 mm to φ15 mm, and more preferably φ6 mm to φ10 mm. The outer diameter of the main body 12 when contracted (when the stent delivery system is accommodated) is about a fraction of the outer diameter when expanded.
 図4に示すように、フレーム部13を構成するストラット13aの線径は、0.05~1mmであることが好ましい。また、ストラット13aの断面が矩形である場合には、ストラット13aの断面における長辺方向の長さが0.06~1mmであって、短辺方向の長さが0.05~0.9mmであることが好ましい。フレーム部13の外径寸法は、上述した本体部12の寸法とほぼ同様である。 As shown in FIG. 4, the wire diameter of the struts 13a constituting the frame portion 13 is preferably 0.05 to 1 mm. When the cross section of the strut 13a is rectangular, the length in the long side direction in the cross section of the strut 13a is 0.06 to 1 mm, and the length in the short side direction is 0.05 to 0.9 mm. Preferably there is. The outer diameter dimension of the frame part 13 is substantially the same as the dimension of the main body part 12 described above.
 フレーム部13の材料としては、樹脂又は金属が使用される。フレーム部13に使用される樹脂としては、適切な硬度と弾性を有するものを使用することが可能であり、生体適合性樹脂であることが好ましい。フレーム部13の材料として使用される樹脂としては、たとえば、ポリオレフィン、ポリエステル、フッ素樹脂などが挙げられる。また、ポリエステルの具体例としては、ポリエチレンテレフタレート、ポリブチレンテレフタレートが挙げられる。また、フッ素樹脂の具体例としては、ポリテトラフルオロエチレン(PTFE)、エチレン・テトラフルオロエチレン共重合体(ETFE)などが挙げられる。 As the material of the frame part 13, resin or metal is used. As resin used for the frame part 13, what has appropriate hardness and elasticity can be used, and it is preferable that it is biocompatible resin. Examples of the resin used as the material of the frame portion 13 include polyolefin, polyester, and fluororesin. Specific examples of the polyester include polyethylene terephthalate and polybutylene terephthalate. Specific examples of the fluororesin include polytetrafluoroethylene (PTFE) and ethylene / tetrafluoroethylene copolymer (ETFE).
 フレーム部13に使用される金属としては、ニッケルチタン(Ni-Ti)合金、ステンレス鋼、タンタル、チタン、コバルトクロム合金、マグネシウム合金等が挙げられるが、Ni-Ti合金のような超弾性合金が好ましい。フレーム部13に使用される超弾性合金の具体例としては、49~58重量%NiのNi-Ti合金が挙げられる。また、Ni-Ti合金中の原子のうち0.01~10.0重量%を他の原子で置換したNi-Ti-X合金(X=Co、Fe、Mn、Cr、V、Al、Nb、W、Bなど)や、Ni-Ti合金中の原子のうち0.01~30.0重量%を他の原子で置換したNi-Ti―X合金(X=Cu、Pb、Zr)等も、フレーム部13の材料として好適である。これらの超弾性合金の機械的特性は、冷間加工率及び/又は最終熱処理の条件を選択することにより調整される。 Examples of the metal used for the frame portion 13 include nickel titanium (Ni—Ti) alloy, stainless steel, tantalum, titanium, cobalt chromium alloy, and magnesium alloy. Superelastic alloys such as Ni—Ti alloy are used. preferable. A specific example of the superelastic alloy used in the frame portion 13 is a Ni—Ti alloy of 49 to 58 wt% Ni. Further, a Ni—Ti—X alloy (X = Co, Fe, Mn, Cr, V, Al, Nb, etc.) in which 0.01 to 10.0% by weight of atoms in the Ni—Ti alloy is substituted with other atoms. W, B, etc.), and Ni—Ti—X alloys (X = Cu, Pb, Zr) in which 0.01 to 30.0% by weight of atoms in the Ni—Ti alloy are substituted with other atoms, etc. It is suitable as a material for the frame portion 13. The mechanical properties of these superelastic alloys are adjusted by selecting the cold work rate and / or the final heat treatment conditions.
 フレーム部13の成形は、たとえば、YAGレーザー等を用いたレーザー加工、放電加工、化学エッチング、切削加工等によって、チューブ状若しくはパイプ状の母材を加工することによって行うことができる。 The frame portion 13 can be formed by processing a tube-shaped or pipe-shaped base material by, for example, laser processing using a YAG laser or the like, electric discharge processing, chemical etching, cutting processing, or the like.
 フレーム部13には、単数又は複数のX線マーカーが設置されていることが好ましい。X線マーカーは、たとえば、X線造影性材料(X線不透過材料)によって構成される。ステント11を体内に留置した際に、X線造影下でX線マーカーの位置を確認することによって、ステント11の留置位置を把握することができる。 It is preferable that one or a plurality of X-ray markers are installed in the frame unit 13. The X-ray marker is made of, for example, an X-ray contrast material (X-ray opaque material). When the stent 11 is placed in the body, the placement position of the stent 11 can be grasped by confirming the position of the X-ray marker under X-ray contrast.
 図2に示すように、本体部12の両端部のうちの一方である第1端部(図2において右端)Rには、複数の第1フッキング部14が設けられている。図4に示すように、第1フッキング部14は、弾性を有しており長手方向D3に延びる線状、棒状又は薄板状の部材により形成されている。図2に示すように、ステント11は、4本の第1フッキング部14を有しているが、ステント11が有する第1フッキング部14の数は、2本又は3本であっても、5本以上であってもよく、特に限定されない。なお、図4は部分展開図であるため、第1フッキング部14は3本しか図示されていない。 As shown in FIG. 2, a plurality of first hooking portions 14 are provided at a first end portion (right end in FIG. 2) R that is one of both end portions of the main body portion 12. As shown in FIG. 4, the first hooking portion 14 is formed of a linear, rod-like, or thin plate-like member that has elasticity and extends in the longitudinal direction D3. As shown in FIG. 2, the stent 11 includes four first hooking portions 14, but the number of the first hooking portions 14 included in the stent 11 may be two or three. It may be more than this, and is not particularly limited. Since FIG. 4 is a partial development view, only three first hooking portions 14 are shown.
 図5は、本体部12の第1端部R及び第1フッキング部14を拡大した部分拡大図である。本体部12は、ストラット13a及び図2に示す被覆フィルム部12aによって周方向に繋がっているのに対して、図5に示す複数の第1フッキング部14は、周方向に互いに繋がっておらず、独立している。 FIG. 5 is a partially enlarged view in which the first end portion R and the first hooking portion 14 of the main body portion 12 are enlarged. The main body portion 12 is connected in the circumferential direction by the struts 13a and the covering film portion 12a shown in FIG. 2, whereas the plurality of first hooking portions 14 shown in FIG. 5 are not connected to each other in the circumferential direction. being independent.
 図2に示すように、第1フッキング部14は、第1端部Rに接続する基端部14bから、自由端である先端部14aまで長手方向D3に沿って、本体部12の外側へ湾曲する湾曲形状を有している。ただし、ステント11が図1(b)に示すようにステントデリバリーシステム50内に収容されている状態では、展開図である図4に示すように、第1フッキング部14が軸方向D2に引き伸ばされた状態であってもよい。この場合、それぞれの第1フッキング部14は、ステント11がステントデリバリーシステム50から放出された際に、自己の弾性力により本体部12の外側へ湾曲するように、くせ付けされている。 As shown in FIG. 2, the first hooking portion 14 curves outward from the main body portion 12 along the longitudinal direction D <b> 3 from the proximal end portion 14 b connected to the first end portion R to the distal end portion 14 a that is a free end. Has a curved shape. However, when the stent 11 is housed in the stent delivery system 50 as shown in FIG. 1B, the first hooking portion 14 is stretched in the axial direction D2 as shown in FIG. It may be in the state. In this case, each first hooking portion 14 is attached to be bent to the outside of the main body portion 12 by its own elastic force when the stent 11 is released from the stent delivery system 50.
 図4及び図5に示すように、本実施形態では、第1フッキング部14はフレーム部13と一体的に形成するものとし、従って第1フッキング部14の基端部14bはフレーム部13(フレーム)の端部に接続されている。第1フッキング部14の断面形状は特に限定されないが、矩形状又は円形状とすることができ、フレーム部13のフレームと同一形状とすることができる。 As shown in FIGS. 4 and 5, in the present embodiment, the first hooking portion 14 is formed integrally with the frame portion 13, and therefore the base end portion 14 b of the first hooking portion 14 is the frame portion 13 (frame ) Is connected to the end. The cross-sectional shape of the first hooking portion 14 is not particularly limited, but may be a rectangular shape or a circular shape, and may be the same shape as the frame of the frame portion 13.
 第1フッキング部14は、フレーム部13とは独立して形成した後に、レーザー溶接等により一体的に固定するようにしてもよいし、フレーム部13を、母材からレーザー加工等によって形成するときに、フレーム部13と一体として切り出すようにしてもよい。この場合において、図2に示すような第1フッキング部14の形状(湾曲形状)は、図4及び図5に示す形状に第1フッキング部14を切り出した後に、切り出した後の第1フッキング部14を図2に示すようにくせ付けすることにより、成形することができる。 The first hooking portion 14 may be formed independently from the frame portion 13 and then fixed integrally by laser welding or the like, or when the frame portion 13 is formed from a base material by laser processing or the like. Alternatively, it may be cut out integrally with the frame portion 13. In this case, the shape (curved shape) of the first hooking portion 14 as shown in FIG. 2 is obtained by cutting the first hooking portion 14 into the shape shown in FIGS. 4 and 5 and then cutting it out. It can shape | mold by attaching 14 as shown in FIG.
 図5に示すように、第1フッキング部14において先端部14aと基端部14bとの間にある中間部14cは、長手方向D3に直交する幅方向D4の長さが第1長さL1である複数の第1部分14caと、第1部分14caに長手方向の両側を挟まれており、幅方向D4の長さが第1長さL1より長い第2長さL2である少なくとも1つの第2部分14cbと、を有する。第1フッキング部14は、複数の第1部分14ca(図5に示す例では4つ)と、複数の第2部分14cb(図5に示す例では3つ)とが、長手方向D3に沿って交互に配置されている。 As shown in FIG. 5, in the first hooking portion 14, the intermediate portion 14c between the distal end portion 14a and the proximal end portion 14b has a first length L1 in the width direction D4 orthogonal to the longitudinal direction D3. A plurality of first portions 14ca and at least one second portion sandwiched on both sides in the longitudinal direction by the first portions 14ca and having a second length L2 in the width direction D4 that is longer than the first length L1. Part 14cb. The first hooking portion 14 includes a plurality of first portions 14ca (four in the example shown in FIG. 5) and a plurality of second portions 14cb (three in the example shown in FIG. 5) along the longitudinal direction D3. Alternatingly arranged.
 図5に示すように、第1部分14caの幅方向D4の長さは、長手方向D3に沿って一定であり、第1長さL1である。これに対して、第2部分14cbの幅方向D4の長さは、長手方向D3に沿って変化しており、最大値が第2長さL2である。それぞれの第2部分14cbの形状は、基端部14bに近い側において幅方向D4に沿って伸びる底辺とフレーム部13の先端部14aに近い側の頂点を有する略二等辺三角形の板状である。このように第2部分14cの基端部14bに近い側を、長手方向D3(中間部14cの伸びる方向)に対して略直交する辺を有する板状とすることにより、第2部分14cbのアンカー効果を高めることができる。 As shown in FIG. 5, the length in the width direction D4 of the first portion 14ca is constant along the longitudinal direction D3 and is the first length L1. On the other hand, the length of the second portion 14cb in the width direction D4 changes along the longitudinal direction D3, and the maximum value is the second length L2. Each of the second portions 14cb has a substantially isosceles triangular plate shape having a base extending along the width direction D4 on the side close to the base end portion 14b and a vertex on the side close to the tip end portion 14a of the frame portion 13. . Thus, by making the side close to the base end portion 14b of the second portion 14c into a plate shape having a side substantially orthogonal to the longitudinal direction D3 (the direction in which the intermediate portion 14c extends), the anchor of the second portion 14cb The effect can be enhanced.
 図5に示すように、第1フッキング部14には、長手方向D3に延びるスリット14dが形成されており、スリット14dが第1部分14ca及び第2部分14cbの幅方向D4中央を通っている。第1フッキング部14の基端部14bは、フレーム部13の第1端部Rにおいて、フレーム部13を構成する三角波状のストラット13aにおける三角波の頂点部(ステント11が径方向に最も収縮した状態を示す図5では蛇行形状のカーブ部分)に、それぞれ接続されている。 As shown in FIG. 5, a slit 14d extending in the longitudinal direction D3 is formed in the first hooking portion 14, and the slit 14d passes through the center in the width direction D4 of the first portion 14ca and the second portion 14cb. The base end part 14b of the first hooking part 14 is the apex part of the triangular wave in the triangular wave strut 13a constituting the frame part 13 (the state where the stent 11 is most contracted in the radial direction) at the first end R of the frame part 13. 5 are respectively connected to a meandering curve portion).
 第1フッキング部14の先端部14aには、管腔臓器の内壁等に当接した際に、該内壁の傷付けを防止するため、図5に示されているように、滑らかな外面を有する略楕円板状の尖端保護部を一体的に設けている。なお、尖端保護部の形状は、第1フッキング部14の先端部14aが、管腔臓器の内壁等に当接した際に、該内壁の傷付けを防止できるものであればよく、略楕円板状以外に、略円板状や略半円板状などであってもよい。また、尖端保護部は、第1フッキング部14の他の部分とは一体的には設けずに、後加工によって、略球状の部材等を取り付けることによって形成してもよい。 The distal end portion 14a of the first hooking portion 14 has a smooth outer surface as shown in FIG. 5 in order to prevent damage to the inner wall when abutting against the inner wall or the like of the luminal organ. An elliptical plate-shaped tip protecting portion is integrally provided. Note that the shape of the tip protection part is not limited as long as the tip part 14a of the first hooking part 14 abuts against the inner wall or the like of the luminal organ. In addition, a substantially disc shape or a substantially semi-disc shape may be used. Moreover, you may form a pointed protection part by attaching a substantially spherical member etc. by post-processing, without providing integrally with the other part of the 1st hooking part 14. FIG.
 図2に示すように、第1フッキング部14の基端部14bと先端部14aとの間の中間部14cは滑らかに湾曲しており、中間部14cにおける基端部14b側の一部は、本体部12の軸方向D2に関して第1端部Rよりも外側(図2において右(Out)側)に位置している。これに対して、第1フッキング部14における中間部14cにおける先端部14a側の他の一部又は先端部14aは、本体部12の軸方向D2に関して第1端部Rよりも内側(図2において左(In)側)に位置している。 As shown in FIG. 2, the intermediate part 14c between the base end part 14b and the front end part 14a of the first hooking part 14 is smoothly curved, and a part of the intermediate part 14c on the base end part 14b side is The main body portion 12 is located outside the first end portion R with respect to the axial direction D2 (on the right (Out) side in FIG. 2). On the other hand, the other part or the tip portion 14a on the tip portion 14a side of the intermediate portion 14c in the first hooking portion 14 is inside the first end portion R with respect to the axial direction D2 of the main body portion 12 (in FIG. 2). It is located on the left (In) side.
 第1フッキング部14の中間部14cにおける基端部14b側の一部は、先端部14a側に行くに従って、ステント11の中心軸Cに対して離間するように形成されている。また、本実施形態では、第1フッキング部14の中間部14cにおける先端部14a側の一部は、先端部14a側に行くに従って、本体部12の中心軸Cに対して近接するように形成され、先端部14aに至っている。すなわち、第1フッキング部14は、基端部14bから先端部14aに向けて、軸方向D2に対する角度θが180°を超えて変化するように湾曲している。 A portion of the intermediate portion 14c of the first hooking portion 14 on the proximal end portion 14b side is formed so as to be separated from the central axis C of the stent 11 toward the distal end portion 14a side. Further, in the present embodiment, a part of the intermediate portion 14c of the first hooking portion 14 on the tip portion 14a side is formed so as to approach the center axis C of the main body portion 12 as it goes to the tip portion 14a side. To the tip 14a. That is, the first hooking portion 14 is curved so that the angle θ with respect to the axial direction D2 changes beyond 180 ° from the base end portion 14b toward the tip end portion 14a.
 第1フッキング部14の形状(湾曲形状)としては、このような形状に限定されず、第1フッキング部14の中間部14cの先端部14a側の一部は、先端部14a側に行くに従って軸線に対して離間するように形成され、先端部14aに至るようにしてもよい。この場合、第1フッキング部14は、基端部14bから先端部14aに向けて、軸方向D2に対する角度θが90°を超えて変化するように湾曲していることが、マイグレーション防止効果を高める上で好ましい。 The shape (curved shape) of the first hooking portion 14 is not limited to such a shape, and a part of the intermediate hooking portion 14c on the distal end portion 14a side of the first hooking portion 14 is an axis line toward the distal end portion 14a side. May be formed so as to be separated from each other and reach the distal end portion 14a. In this case, the first hooking portion 14 is curved so that the angle θ with respect to the axial direction D2 changes beyond 90 ° from the base end portion 14b toward the tip end portion 14a, thereby enhancing the migration prevention effect. Preferred above.
 第1フッキング部14の湾曲形状は、全体的に一様な曲率としてもよいし、先端部14aに行くに従って連続的に又は段階的に曲率を変化させるようにしてもよい。たとえば、中間部14cにおける基端部14b側の一部の曲率を、これより先端部14a側の他の一部の曲率より大きくしてもよく、又は小さくしてもよい。なお、第1フッキング部14の湾曲形状の一部に単一又は複数の直線部を介装してもよい。また、第1フッキング部14の湾曲形状は、1つの変曲点を有する曲線に限られず、2つ又はそれ以上の変曲点を有する曲線としてもよい。 The curved shape of the first hooking part 14 may be a uniform curvature as a whole, or the curvature may be changed continuously or stepwise as it goes to the tip part 14a. For example, the curvature of a part of the intermediate part 14c on the base end part 14b side may be larger or smaller than that of the other part of the curvature on the distal end part 14a side. In addition, you may interpose a single or some linear part in a part of curved shape of the 1st hooking part 14. FIG. Further, the curved shape of the first hooking unit 14 is not limited to a curve having one inflection point, and may be a curve having two or more inflection points.
 第1フッキング部14の数及び配置としては、この実施形態では4つとし、それぞれを均等角度間隔(すなわち、90°)で略放射状に配置しているが、その数は2つ、3つ、又は5つ以上であってもよい。第1フッキング部14の配置は、均等角度間隔で配置してもよいが、必ずしもそれに限定されず、適用される管腔臓器の種類や形状等に応じて適宜に選定することができる。また、本実施形態では、複数の第1フッキング部14の構成(湾曲形状、長さ等)は、全て(本実施形態では、4つ)について互いに同一のものとするが、これらの内の1つ又は複数を異なる構成(湾曲形状、長さ等)としてもよい。 In this embodiment, the number and arrangement of the first hooking portions 14 are four, and the first hooking portions 14 are arranged substantially radially at equal angular intervals (ie, 90 °), but the number is two, three, Or five or more may be sufficient. Although arrangement | positioning of the 1st hooking part 14 may be arrange | positioned at equal angle intervals, it is not necessarily limited to it, It can select suitably according to the kind, shape, etc. of the luminal organ applied. In the present embodiment, the configuration (curved shape, length, etc.) of the plurality of first hooking portions 14 is the same for all (four in the present embodiment). One or more may have different configurations (curved shape, length, etc.).
 図2及び図4に示すように、本体部12の両端部のうちの他方である第2端部(図2及び図4において左端)Lには、複数の第2フッキング部15が設けられている。図2に示すように、第2フッキング部15は、第2端部Lに接続する基端部15bから、自由端である先端部15aまで長手方向D3に沿って、本体部12の外側へ湾曲する湾曲形状を有している。 As shown in FIGS. 2 and 4, a plurality of second hooking portions 15 are provided at a second end portion (left end in FIGS. 2 and 4) L which is the other end portion of the main body portion 12. Yes. As shown in FIG. 2, the second hooking portion 15 curves outward from the main body portion 12 along the longitudinal direction D3 from the proximal end portion 15b connected to the second end portion L to the distal end portion 15a that is a free end. Has a curved shape.
 図4に示すように、第2フッキング部15は、第1フッキング部14と同様に、先端部15a、基端部15b及び中間部15cを有しており、第2フッキング部15の中間部15cは、第1フッキング部14の中間部14cと同様に、第1部分15caと第2部分15cbとを有する。複数の第2フッキング部15は、第1端部Rではなく第2端部Lに設けられていることを除き、上述した第1フッキング部14と同様の形状及び構造を有するため、第2フッキング部15の詳細構造については、説明を省略する。 As shown in FIG. 4, the second hooking portion 15 has a distal end portion 15 a, a proximal end portion 15 b, and an intermediate portion 15 c, similar to the first hooking portion 14, and the intermediate portion 15 c of the second hooking portion 15. Has a first portion 15ca and a second portion 15cb, similar to the intermediate portion 14c of the first hooking portion 14. The plurality of second hooking portions 15 have the same shape and structure as the first hooking portion 14 described above except that the second hooking portions 15 are provided not at the first end portion R but at the second end portion L. Description of the detailed structure of the unit 15 is omitted.
 上述したように、図2等に示すステント11は、第1及び第2フッキング部14、15の中間部14c、15cに、幅方向D4の長さが異なる第1部分14ca、15caと第2部分14cb、15cbとを有するため、特に幅方向D4の長さが長い第2部分14cb、15cbや、第1部分14ca、15caと第2部分14cb、15cbとの基端部14b、15b側の境界部が、ステント11が体内の留置位置から移動することを妨げるアンカーとして機能する。したがって、このようなステント11は、マイグレーションを効果的に防止することができる。 As described above, the stent 11 shown in FIG. 2 and the like has the first portions 14ca, 15ca and the second portion having different lengths in the width direction D4 in the intermediate portions 14c, 15c of the first and second hooking portions 14, 15. 14cb and 15cb, the second portions 14cb and 15cb that are particularly long in the width direction D4, and the boundary portions on the base end portions 14b and 15b side between the first portions 14ca and 15ca and the second portions 14cb and 15cb. However, it functions as an anchor that prevents the stent 11 from moving from the indwelling position in the body. Therefore, such a stent 11 can effectively prevent migration.
 また、第1フッキング部14の中間部14cにおける基端部14b側の一部は、本体部12の軸方向D2に関して第1端部Rよりも外側(図2において右(Out)側)に位置しているとともに、先端部14a(又は中間部14cにおける先端部14a側の他の一部)は、本体部12の軸方向D2に関して第1端部Rよりも内側(図2において左(In)側)に位置しているため、このステント11を体内に留置した場合に、第1フッキング部14の先端部14a(又は中間部14cの先端部14a側の他の一部)が管腔臓器の内壁に当接し、第1フッキング部14の弾性により、本体部12の第1端部Rが管腔臓器の内壁から管腔臓器内側に僅かに突き出して管腔臓器内に入り込んだ状態で保持される。従って、本体部12が管腔臓器の内壁の外側(体腔内側)に入り込む方向におけるマイグレーションが防止されることに加えて、本体部12の第1端部Rが管腔臓器から逸脱して、体腔内側に入り込んでしまう事象が防止され、ステント11の周囲の体腔内(管腔臓器外)に胆汁等の消化液や消化された食物等が漏出することを効果的に抑制することができる。 Further, a portion of the intermediate portion 14c of the first hooking portion 14 on the base end portion 14b side is located outside the first end portion R with respect to the axial direction D2 of the main body portion 12 (on the right (Out) side in FIG. 2). In addition, the distal end portion 14a (or another part on the distal end portion 14a side in the intermediate portion 14c) is located on the inner side (left (In) in FIG. 2) of the first end R with respect to the axial direction D2 of the main body portion 12. When the stent 11 is indwelled in the body, the distal end portion 14a of the first hooking portion 14 (or the other portion of the intermediate portion 14c on the distal end portion 14a side) is a luminal organ. Due to the elasticity of the first hooking portion 14, the first end R of the main body portion 12 slightly protrudes from the inner wall of the luminal organ to the inside of the luminal organ and is held in the luminal organ due to the elasticity of the first hooking portion 14. The Accordingly, in addition to preventing migration in the direction in which the main body 12 enters the outside (inside the body cavity) of the inner wall of the luminal organ, the first end R of the main body 12 deviates from the luminal organ, and the body cavity The event of entering the inside is prevented, and leakage of digestive fluid such as bile or digested food into the body cavity (outside the luminal organ) around the stent 11 can be effectively suppressed.
 また、ステント11では、本体部12の第2端部L側に第2フッキング部15が設けられているため、第2端部L側についても、第1端部R側と同様の効果を奏する。ただし、ステント11は、これとは異なり、本体部12の両端部のうち一方のみに第1フッキング部14又は第2フッキング部15が設けられていてもよい。 Moreover, in the stent 11, since the 2nd hooking part 15 is provided in the 2nd end part L side of the main-body part 12, there exists an effect similar to the 1st end part R side also about the 2nd end part L side. . However, unlike the stent 11, the first hooking portion 14 or the second hooking portion 15 may be provided in only one of both end portions of the main body portion 12.
 以上のように、実施形態を挙げて本発明を説明したが、本発明は、上述した実施形態のみに限定されるものではなく、他の実施形態や変形例を含むことは言うまでもない。たとえば、1つの第1又は第2フッキング部14、15の中間部14c、15cが有する第2部分14cb、15cbの数や大きさは特に限定されず、配置位置の状態やステント11の大きさなどに応じて変更することができる。また、第2部分14cb、15cbの形状も、図2及び図5に示すような三角形の板状に限定されず、他の多角形や円形の板状又は球形状など、三角形の板状以外の形状を採用してもよい。 As described above, the present invention has been described with reference to the embodiment. However, the present invention is not limited to the above-described embodiment, and needless to say, includes other embodiments and modifications. For example, the number and size of the second portions 14cb and 15cb included in the intermediate portions 14c and 15c of the first or second hooking portions 14 and 15 are not particularly limited, and the state of the arrangement position, the size of the stent 11, etc. It can be changed according to. Further, the shape of the second portions 14cb and 15cb is not limited to the triangular plate shape as shown in FIGS. 2 and 5, and other shapes other than the triangular plate shape such as a polygonal shape, a circular plate shape or a spherical shape are used. A shape may be adopted.
 図6は、第1変形例に係るステントにおける本体部(フレーム部13)の第1端部R及び第1端部Rに設けられる第1フッキング部114を表す部分拡大図である。第2変形例に係るステントにおける第1フッキング部114は、中間部114cにおける第2部分114cbの形状及び数が、実施形態に示す第1フッキング部14(図5参照)とは異なる。図6に示すように、第1フッキング部14の中間部114cは、長手方向D3に直交する幅方向D4の長さが第1長さL1である3つの第1部分114caと、第1部分114caに長手方向D3の両側を挟まれており、幅方向D4の長さが第1長さL1より長い第2長さL2である2つの第2部分114cbと、を有する。 FIG. 6 is a partially enlarged view showing the first end portion R and the first hooking portion 114 provided at the first end portion R of the main body portion (frame portion 13) in the stent according to the first modification. The first hooking portion 114 in the stent according to the second modification is different from the first hooking portion 14 (see FIG. 5) shown in the embodiment in the shape and number of the second portions 114cb in the intermediate portion 114c. As shown in FIG. 6, the intermediate portion 114c of the first hooking portion 14 includes three first portions 114ca having a first length L1 in the width direction D4 orthogonal to the longitudinal direction D3, and a first portion 114ca. And two second portions 114cb having a second length L2 in which the length in the width direction D4 is longer than the first length L1.
 中間部114cの第2部分114cbの形状は、楕円形の板状であり、基端部14bに近い側と先端部14aに近い側とが対称となっている。このような中間部114cも、ステントが体内の留置位置から移動することを妨げるアンカーとして機能し、ステントのマイグレーションを防止することができる。なお、第1変形例に係るステントは、中間部114cにおける第2部分114cbの形状及び数が異なることを除き、第2実施形態に係るステントと同様であるため、ステント11との共通部分については、説明を省略する。また、図6に示す部分拡大図では示されていないが、第1変形例に係るステントの第1フッキング部114も、第1端部Rに接続する基端部14bから、自由端である先端部14aへ向かう長手方向D3に沿って、本体部12の外側へ湾曲する湾曲形状を有している点については、第1フッキング部14と同様である。 The shape of the second portion 114cb of the intermediate portion 114c is an elliptical plate shape, and the side close to the base end portion 14b and the side close to the tip end portion 14a are symmetrical. Such an intermediate portion 114c also functions as an anchor that prevents the stent from moving from the indwelling position in the body, and can prevent migration of the stent. The stent according to the first modification is the same as the stent according to the second embodiment except that the shape and number of the second portions 114cb in the intermediate portion 114c are different. The description is omitted. Although not shown in the partial enlarged view shown in FIG. 6, the first hooking portion 114 of the stent according to the first modified example is also a distal end that is a free end from the proximal end portion 14 b connected to the first end portion R. It is the same as that of the 1st hooking part 14 about having the curved shape which curves outside the main-body part 12 along the longitudinal direction D3 which goes to the part 14a.
 図7は、第2変形例に係るステントにおける本体部(フレーム部13)の第1端部Rおよび第1端部Rに設けられる第1フッキング部を表す部分拡大図である。第2変形例に係るステントは、第1端部Rに設けられる複数の第1フッキング部が、互いに形状の異なる第1タイプの第1フッキング部24と、第2タイプの第1フッキング部44とを含む点で、図5に示すステント11とは異なる。 FIG. 7 is a partially enlarged view showing the first end portion R and the first hooking portion provided at the first end portion R of the main body portion (frame portion 13) in the stent according to the second modified example. The stent according to the second modification includes a first type of first hooking portion 24, a second type of first hooking portion 44, and a plurality of first hooking portions provided at the first end R having different shapes. Is different from the stent 11 shown in FIG.
 図7に示すように、第1タイプの第1フッキング部24は、第1端部Rに接続する基端部24bと、自由端である先端部24aと、基端部24bと先端部24aとの間にある中間部24cを有している。中間部24cは、長手方向D3に直交する幅方向D4の長さが第1長さL1である4つの第1部分24caと、第1部分24caに長手方向D3の両側を挟まれており、幅方向D4の長さが第1長さL1より長い第2長さL2である3つの第2部分24cbと、を有する。それぞれの第2部分24cbの形状は、長手方向D3に沿う2辺と幅方向D4に沿う2辺を有する矩形板状である。先端部24aには、略楕円板状の尖端保護部が設けられている。 As shown in FIG. 7, the first type first hooking portion 24 includes a base end portion 24b connected to the first end portion R, a tip end portion 24a that is a free end, a base end portion 24b, and a tip end portion 24a. The intermediate portion 24c is located between the two. The intermediate portion 24c is sandwiched between four first portions 24ca whose length in the width direction D4 perpendicular to the longitudinal direction D3 is the first length L1, and both sides of the longitudinal direction D3 between the first portions 24ca. Three second portions 24cb having a length in the direction D4 and a second length L2 longer than the first length L1. The shape of each second portion 24cb is a rectangular plate shape having two sides along the longitudinal direction D3 and two sides along the width direction D4. The tip portion 24a is provided with a substantially elliptical plate-shaped tip protecting portion.
 第2タイプの第1フッキング部44は、第1タイプの第1フッキング部24に対して、周方向に隣接して配置されており、第1タイプの第1フッキング部24とは形状が異なる。図7に示すように、第2変形例のステントにおける第1端部Rには、第1タイプの第1フッキング部24と、第2タイプの第1フッキング部44とが、周方向に交互に設けられている。 The second type first hooking part 44 is arranged adjacent to the first type first hooking part 24 in the circumferential direction, and is different in shape from the first type first hooking part 24. As shown in FIG. 7, the first type first hooking portion 24 and the second type first hooking portion 44 are alternately arranged in the circumferential direction at the first end R in the stent of the second modified example. Is provided.
 第2タイプの第1フッキング部44は、第1端部Rに接続する基端部44bと、自由端である先端部44aと、基端部44bと先端部44aとの間にある中間部44cを有している。中間部44cは、長手方向D3に直交する幅方向D4の長さが第1長さL1である2つの第1部分44caと、第1部分44caに長手方向D3の両側を挟まれており、幅方向D4の長さが第1長さL1より長い第2長さL2である3つの第2部分44cbと、を有する。基端部44bには貫通穴が形成されてリング状になっており、先端部44aは中間部44cの第1部分44caと同じ幅方向D4の長さを有する。中間部44cにおける第2部分44cbの形状は、第1タイプの第1フッキング部24の第2部分24cbと同様、矩形板状である。 The first hooking part 44 of the second type includes a base end part 44b connected to the first end part R, a free end part 44a, and an intermediate part 44c between the base end part 44b and the front end part 44a. have. The intermediate portion 44c is sandwiched between two first portions 44ca having a first length L1 in the width direction D4 perpendicular to the longitudinal direction D3, and both sides of the longitudinal direction D3 between the first portions 44ca. Three second portions 44cb whose length in the direction D4 is a second length L2 longer than the first length L1. A through hole is formed in the base end portion 44b to form a ring shape, and the tip end portion 44a has the same length in the width direction D4 as the first portion 44ca of the intermediate portion 44c. The shape of the second portion 44cb in the intermediate portion 44c is a rectangular plate shape like the second portion 24cb of the first hooking portion 24 of the first type.
 図7に示すように、第1タイプの第1フッキング部24と、第2タイプの第1フッキング部44とでは、中間部24c、44cにおける第1部分24ca、44cb及び第2部分24cb、44cbの長手方向D3の配置が異なる。すなわち、第1フッキング部24、44における長手方向D3の位置に関して、第1タイプの第1フッキング部24において第1部分24caが配置されている位置に、第2タイプの第1フッキング部44では第2部分44cbが配置されている。また、第1タイプの第1フッキング部24において第2部分24cbが配置されている位置に、第2タイプの第1フッキング部44では第1部分44caが配置されている。 As shown in FIG. 7, in the first type first hooking portion 24 and the second type first hooking portion 44, the first portions 24ca and 44cb and the second portions 24cb and 44cb in the intermediate portions 24c and 44c The arrangement in the longitudinal direction D3 is different. That is, with respect to the position of the first hooking portions 24 and 44 in the longitudinal direction D3, the first hooking portion 44 of the second type is located at the position where the first portion 24ca is disposed in the first hooking portion 24 of the first type. Two portions 44cb are arranged. Further, in the first type first hooking part 24, the first part 44ca is arranged in the second type first hooking part 44 at the position where the second part 24cb is arranged.
 図7に示すように、第2変形例に係るステントでは、周方向に隣接して配置される第1タイプの第1フッキング部24と第2タイプの第1フッキング部44との間で、幅方向D4の長さが長い第2部分24cb、44cbの位置が互い違いになっている。このようなステントでは、図7に示すように、第2部分24cb、44cbを、互いに幅方向に重複することなく密に形成してあるので、第2部分24cb、44cbの第2長さL2を長くしても、ステントデリバリーシステム50に収容される際において、それぞれの第2部分24cb、44cbが互いに邪魔になりにくく、第2長さL2をより長いものとすることによって、マイグレーション防止効果を高めることができる。また、図7に示すように、第1タイプの第1フッキング部24における第2部分24cbと、第2タイプの第1フッキング部44における第2部分44cbとが、軸方向D2に重複する部分Pが形成されることにより、このようなステントは、ステントデリバリーシステム50から放出する際における押し出し易さが良好である。 As shown in FIG. 7, in the stent according to the second modified example, the width between the first type first hooking portion 24 and the second type first hooking portion 44 arranged adjacent to each other in the circumferential direction is different. The positions of the second portions 24cb and 44cb having a long length in the direction D4 are staggered. In such a stent, as shown in FIG. 7, since the second portions 24cb and 44cb are formed densely without overlapping each other in the width direction, the second length L2 of the second portions 24cb and 44cb is set as follows. Even if the length is longer, the second portions 24cb and 44cb are less likely to interfere with each other when housed in the stent delivery system 50, and the second length L2 is made longer, thereby increasing the migration prevention effect. be able to. Further, as shown in FIG. 7, the portion P where the second portion 24cb of the first hooking portion 24 of the first type and the second portion 44cb of the first hooking portion 44 of the second type overlap in the axial direction D2. By forming the above, such a stent has good extrudability when released from the stent delivery system 50.
 すなわち、図1に示すようなステントデリバリーシステム50に収容される際、図7に示す第2変形例に係るステントは、図7に示すように第1フッキング部24、44が軸方向D2に引き延ばされた状態で収容される。また、ステントデリバリーシステム50がステントを留置位置に放出する際、収容されたステントは、アウターシース66との間で生じる摩擦力に伴う軸方向D2の力に抗して、プッシュリング69によって軸方向D2に押されることにより、アウターシース66から露出される。このとき、第1フッキング部24、44は周方向に繋がっておらず独立しているため、プッシュリング69によって先端部24a、44aから軸方向D2に押された場合に、軸方向D2に押しつぶされる懸念があるとも考えられる。しかしながら、第2変形例に係るステントでは、図7に示すように第2部分24cb、44cbが軸方向D2に重複する部分Pが形成されているため、放出時の軸方向D2の力を第1フッキング部24、44が受け止め、アウターシース66から円滑に露出させることができる。 That is, when accommodated in the stent delivery system 50 as shown in FIG. 1, the stent according to the second modification shown in FIG. 7 has the first hooking portions 24 and 44 pulled in the axial direction D2 as shown in FIG. It is accommodated in an extended state. Further, when the stent delivery system 50 releases the stent to the indwelling position, the accommodated stent is axially moved by the push ring 69 against the axial force D2 caused by the frictional force generated between the stent delivery system 50 and the outer sheath 66. By being pushed by D2, it is exposed from the outer sheath 66. At this time, since the first hooking parts 24 and 44 are not connected in the circumferential direction and are independent, when pushed in the axial direction D2 from the front end parts 24a and 44a by the push ring 69, they are crushed in the axial direction D2. There may be concerns. However, in the stent according to the second modification example, as shown in FIG. 7, since the portion P where the second portions 24cb and 44cb overlap in the axial direction D2 is formed, the force in the axial direction D2 at the time of discharge is the first. The hooking portions 24 and 44 can be received and can be smoothly exposed from the outer sheath 66.
 図7に示すような第1フッキング部24、44は、本体部12の両端部に設けられていてもよく、一方の端部にのみ設けられていてもよい。ただし、一方の端部にのみに設ける場合は、放出時において第1フッキング部24、44が設けられている側が、ステントがプッシュリング69に押されるように、搬送機構52に収容されることが好ましい。 The first hooking parts 24 and 44 as shown in FIG. 7 may be provided at both end parts of the main body part 12, or may be provided only at one end part. However, when it is provided only at one end, the side where the first hooking parts 24 and 44 are provided at the time of release may be accommodated in the transport mechanism 52 so that the stent is pushed by the push ring 69. preferable.
11…管腔臓器間バイパス用ステント
12…本体部
12a…被覆フィルム部
12aa…第1のポリマーフィルム
12ab…第2のポリマーフィルム
12b…ステント内周表面
12c…コーティング膜
R…第1端部
L…第2端部
13…フレーム部
13a…ストラット
13b…ブリッジ
14、114…第1フッキング部
24…第1タイプの第1フッキング部
44…第2タイプの第1フッキング部
15…第2フッキング部
14a、15a、24a、44a…先端部
14b、15b、24b、44b…基端部
14c、15c、114c、24c、44c…中間部
14ca、15ca、114ca、24ca、44ca…第1部分
14cb、15cb、114cb、24cb、44cb…第2部分
50…ステントデリバリーシステム
52…搬送機構
60…操作部
61…ハウジング
62…先端チップ
63…操作レバー
64…最外管
66…アウターシース
68…インナーシャフト
69…プッシュリング
D1…デリバリーシステムの軸方向
D2…本体部の軸方向
D3…長手方向
D4…幅方向
P…重複する部分
C…中心軸
θ…角度
L1…第1長さ
L2…第2長さ
DESCRIPTION OF SYMBOLS 11 ... Luminal organ bypass stent 12 ... Main-body part 12a ... Cover | coated film part 12aa ... 1st polymer film 12ab ... 2nd polymer film 12b ... Stent inner peripheral surface 12c ... Coating film R ... 1st edge L ... Second end portion 13 ... Frame portion 13a ... Strut 13b ... Bridge 14, 114 ... First hooking portion 24 ... First type first hooking portion 44 ... Second type first hooking portion 15 ... Second hooking portion 14a, 15a, 24a, 44a ... distal end portions 14b, 15b, 24b, 44b ... proximal end portions 14c, 15c, 114c, 24c, 44c ... intermediate portions 14ca, 15ca, 114ca, 24ca, 44ca ... first portions 14cb, 15cb, 114cb, 24cb, 44cb ... second part 50 ... stent delivery system 52 ... transport mechanism 60 Operation part 61 ... Housing 62 ... Tip tip 63 ... Operation lever 64 ... Outer tube 66 ... Outer sheath 68 ... Inner shaft 69 ... Push ring D1 ... Axial direction D2 of delivery system ... Axial direction D3 of main body ... Longitudinal direction D4 ... Width direction P ... overlapping portion C ... central axis θ ... angle L1 ... first length L2 ... second length

Claims (8)

  1.  管腔臓器と他の管腔臓器とをバイパス接続するための管腔臓器間バイパス用ステントであって、 
     周方向に繋がっている細長い筒状の本体部と、 
     前記本体部の軸方向の両端部のうちの一方である第1端部に接続する基端部から、自由端である先端部へ向かう長手方向に沿って、前記本体部の外径側へ湾曲する湾曲形状を有しており、前記周方向には互いに繋がっておらず独立している複数の第1フッキング部と、を有し、
     前記第1フッキング部において前記先端部と前記基端部との間にある中間部は、前記長手方向に直交する幅方向の長さが第1長さである複数の第1部分と、前記第1部分に前記長手方向の両側を挟まれており、前記幅方向の長さが前記第1長さより長い第2長さである少なくとも1つの第2部分と、を有することを特徴とする管腔臓器間バイパス用ステント。
    A stent for bypassing a luminal organ for bypassing a luminal organ and another luminal organ,
    An elongated cylindrical body connected in the circumferential direction;
    Curved from the base end connected to the first end, which is one of the two axial ends of the main body, to the outer diameter side of the main body along the longitudinal direction toward the distal end, which is a free end. A plurality of first hooking portions that are independent of each other and are not connected to each other in the circumferential direction.
    In the first hooking portion, an intermediate portion between the distal end portion and the proximal end portion includes a plurality of first portions having a first length in the width direction orthogonal to the longitudinal direction, and the first portion A lumen having at least one second portion sandwiched between the two sides in the longitudinal direction and having a second length that is longer than the first length in the width direction; Stent for inter-organ bypass.
  2.  前記複数の前記第1フッキング部には、前記周方向に隣接して配置されており、互いに形状の異なる第1タイプの前記第1フッキング部と、第2タイプの前記第1フッキング部とが含まれ、
     前記長手方向の位置に関して、前記第1タイプの前記第1フッキング部において前記第1部分が配置されている位置に、前記第2タイプの前記第1フッキング部では前記第2部分が配置されていることを特徴とする請求項1に記載の管腔臓器間バイパス用ステント。
    The plurality of first hooking portions are arranged adjacent to each other in the circumferential direction, and include the first type of the first hooking portion and the second type of the first hooking portion that have different shapes. And
    Regarding the position in the longitudinal direction, the second part is arranged in the first hooking part of the second type at the position where the first part is arranged in the first hooking part of the first type. The stent for bypass between luminal organs according to claim 1 characterized by things.
  3.  前記第1フッキング部は、前記基端部から前記先端部に向けて、前記軸方向に対する角度が90°を超えて変化するように湾曲していることを特徴とする請求項1又は請求項2に記載の管腔臓器間バイパス用ステント。 The first hooking portion is curved from the base end portion toward the tip end portion so that an angle with respect to the axial direction changes more than 90 °. The stent for bypass between luminal organs described in 1.
  4.  前記第1フッキング部において、前記中間部における前記基端部側の一部は、前記軸方向に関して前記第1端部よりも外側に位置し、
     前記第1フッキング部において、前記中間部における前記先端部側の他の一部又は前記先端部は、前記軸方向に関して前記第1端部よりも内側に位置していることを特徴とする請求項1から請求項3までのいずれかに記載の管腔臓器間バイパス用ステント。
    In the first hooking portion, a part of the intermediate portion on the base end side is located outside the first end with respect to the axial direction,
    2. The first hooking part, wherein another part of the intermediate part on the tip part side or the tip part is positioned inside the first end part with respect to the axial direction. The stent for bypass between luminal organs according to any one of claims 1 to 3.
  5.  前記本体部の前記両端部のうちの他方である第2端部に接続する基端部から、自由端である先端部へ向かう長手方向に沿って、前記本体部の外側へ湾曲する湾曲形状を有しており、前記周方向には互いに繋がっておらず独立している複数の第2フッキング部をさらに有し、
     前記第2フッキング部において前記先端部と前記基端部との間にある中間部は、前記長手方向に直交する幅方向の長さが第1長さである複数の第1部分と、前記第1部分に前記長手方向の両側を挟まれており、前記幅方向の長さが前記第1長さより長い第2長さである少なくとも1つの第2部分と、を有することを特徴とする請求項1から請求項4までのいずれかに記載の管腔臓器間バイパス用ステント。
    A curved shape that curves to the outside of the main body portion along the longitudinal direction from the base end portion connected to the second end portion that is the other of the both end portions of the main body portion to the distal end portion that is a free end. A plurality of second hooking portions that are independent of each other and are not connected to each other in the circumferential direction;
    In the second hooking portion, an intermediate portion between the distal end portion and the proximal end portion includes a plurality of first portions whose length in the width direction orthogonal to the longitudinal direction is a first length, and the first portion And at least one second portion having a second length that is longer than the first length and sandwiched on both sides in the longitudinal direction by one portion. The stent for bypass between luminal organs according to any one of claims 1 to 4.
  6.  前記第2フッキング部は、前記基端部から前記先端部に向けて、前記軸方向に対する角度が90°を超えて変化するように湾曲していることを特徴とする請求項5に記載の管腔臓器間バイパス用ステント。 6. The tube according to claim 5, wherein the second hooking portion is curved from the base end portion toward the tip end portion so that an angle with respect to the axial direction changes more than 90 °. Stent for inter-cavity bypass.
  7.  前記第2フッキング部において、前記中間部における前記基端部側の一部は、前記軸方向に関して前記第1端部よりも外側に位置し、
     前記第2フッキング部において、前記中間部における前記先端部側の他の一部又は前記先端部は、前記軸方向に関して前記第1端部よりも内側に位置していることを特徴とする請求項5又は請求項6に記載の管腔臓器間バイパス用ステント。
    In the second hooking portion, a part of the intermediate portion on the base end side is located outside the first end with respect to the axial direction.
    2. The second hooking part, wherein the other part of the intermediate part or the tip part is located inside the first end part with respect to the axial direction. A stent for bypassing a luminal organ according to claim 5 or 6.
  8.  請求項1から請求項7までのいずれかに記載の管腔臓器間バイパス用ステントと、
     前記管腔臓器間バイパス用ステントを体内の所定の位置に搬送する搬送機構と、を有するステントデリバリーシステム。
    The stent for luminal organ bypass according to any one of claims 1 to 7,
    A stent delivery system comprising: a transport mechanism for transporting the lumen-organ bypass stent to a predetermined position in the body.
PCT/JP2019/013257 2018-03-30 2019-03-27 Luminal organ bypass stent and stent delivery system including luminal organ bypass stent WO2019189398A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020509211A JP7351292B2 (en) 2018-03-30 2019-03-27 A stent delivery system including a stent for luminal interorgan bypass and a stent for luminal interorgan bypass

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018-068864 2018-03-30
JP2018068864 2018-03-30

Publications (1)

Publication Number Publication Date
WO2019189398A1 true WO2019189398A1 (en) 2019-10-03

Family

ID=68059057

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2019/013257 WO2019189398A1 (en) 2018-03-30 2019-03-27 Luminal organ bypass stent and stent delivery system including luminal organ bypass stent

Country Status (2)

Country Link
JP (1) JP7351292B2 (en)
WO (1) WO2019189398A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012071031A1 (en) * 2010-11-23 2012-05-31 Treus Medical, Inc Biliary shunts, delivery systems, and methods of using the same
US20150157479A1 (en) * 2012-04-04 2015-06-11 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
JP2017176666A (en) * 2016-03-31 2017-10-05 日本ゼオン株式会社 Stent delivery system

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012071031A1 (en) * 2010-11-23 2012-05-31 Treus Medical, Inc Biliary shunts, delivery systems, and methods of using the same
US20150157479A1 (en) * 2012-04-04 2015-06-11 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
JP2017176666A (en) * 2016-03-31 2017-10-05 日本ゼオン株式会社 Stent delivery system

Also Published As

Publication number Publication date
JP7351292B2 (en) 2023-09-27
JPWO2019189398A1 (en) 2021-03-25

Similar Documents

Publication Publication Date Title
US8343205B2 (en) Stent delivery system
EP2702964B1 (en) Stent
JP2016508432A (en) A medical device used through at least one of the bile duct and pancreatic duct
WO2019230413A1 (en) Stent for bypass between hollow organs and stent delivery system including stent for bypass between hollow organs
JP5791521B2 (en) Stent delivery system
JP6724490B2 (en) Stent delivery system
JP2006223728A (en) Catheter
JP6167811B2 (en) Stent for luminal organ bypass
JP2013223663A (en) Protective sleeve for balloon catheter, balloon catheter system, and stent delivery system
JP7120221B2 (en) stent delivery device
WO2017142968A1 (en) Bioresorbable scaffold delivery system with improved distal integrity
WO2020162287A1 (en) Extension catheter and method for producing same
WO2007034639A1 (en) Stent delivery catheter
WO2019189398A1 (en) Luminal organ bypass stent and stent delivery system including luminal organ bypass stent
JP2013223664A (en) Protective sleeve for balloon catheter, balloon catheter system, and stent delivery system
JP7329043B2 (en) Medical tubular body conveying device
JP2022019920A (en) Stent with atraumatic spacer
JP2008086340A (en) Stent delivery catheter
JP2016116815A (en) Indwelling implement delivery device
JP7298598B2 (en) stent delivery system
JP6605907B2 (en) Stent
JP7439619B2 (en) Stent for luminal interorgan bypass
JP2022157271A (en) Stent for bypassing between luminal organs
WO2023189378A1 (en) Catheter
JP2018171372A (en) catheter

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19778189

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2020509211

Country of ref document: JP

Kind code of ref document: A

122 Ep: pct application non-entry in european phase

Ref document number: 19778189

Country of ref document: EP

Kind code of ref document: A1